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Introduction: Bone is an integral part of the osteoarthritis (OA) process. We conducted a systematic literature review
in order to understand the relationship between non-conventional radiographic imaging of subchondral bone, pain,
structural pathology and joint replacement in peripheral joint OA.
Methods: A search of the Medline, EMBASE and Cochrane library databases was performed for original articles
reporting association between non-conventional radiographic imaging-assessed subchondral bone pathologies
and joint replacement, pain or structural progression in knee, hip, hand, ankle and foot OA. Each association was
qualitatively characterised by a synthesis of the data from each analysis based upon study design, adequacy of
covariate adjustment and quality scoring.
Results: In total 2456 abstracts were screened and 139 papers were included (70 cross-sectional, 71 longitudinal
analyses; 116 knee, 15 hip, six hand, two ankle and involved 113 MRI, eight DXA, four CT, eight scintigraphic and
eight 2D shape analyses). BMLs, osteophytes and bone shape were independently associated with structural
progression or joint replacement. BMLs and bone shape were independently associated with longitudinal change
in pain and incident frequent knee pain respectively.
Conclusion: Subchondral bone features have independent associations with structural progression, pain and
joint replacement in peripheral OA in the hip and hand but especially in the knee. For peripheral OA sites other
than the knee, there are fewer associations and independent associations of bone pathologies with these
important OA outcomes which may reflect fewer studies; for example the foot and ankle were poorly studied.
Subchondral OA bone appears to be a relevant therapeutic target.
Systematic review: PROSPERO registration number: CRD 42013005009Introduction
Osteoarthritis (OA), the most common form of arthritis,
is a major cause of chronic pain and disability. OA confers
a huge burden on both individuals and health economies
[1, 2]. There are currently no licensed disease-modifying
osteoarthritis drugs (DMOADs) but ideally these should* Correspondence: p.conaghan@leeds.ac.uk
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and/or function [3, 4]. While hyaline cartilage loss is the
hallmark pathology, clinical OA usually involves multiple
tissues. Describing the relationships of these tissues with
structural progression and symptoms may identify poten-
tial tissue targets.
The subchondral bone in particular is intimately associ-
ated with hyaline cartilage and therefore a tissue of great
potential interest. Conventional radiographs are known to
be relatively insensitive to the structural features of OA
[5], in part because they do not assess three-dimensionaldistributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
ro/1.0/) applies to the data made available in this article, unless otherwise stated.
Barr et al. Arthritis Research & Therapy  (2015) 17:228 Page 2 of 36(3D) bone structure [6]. A number of non-conventional
radiographic imaging modalities accurately demonstrate
in vivo subchondral bone pathological changes, includ-
ing magnetic resonance imaging (MRI), computed tom-
ography (CT), dual-energy x-ray absorptiometry (DXA),
scintigraphy and positron emission tomography (PET)
[5, 7–13]. Hunter and colleagues found a moderate associ-
ation between bone marrow lesions (BMLs), structural
progression and longitudinal change in pain in a system-
atic review focused on MRI biomarkers and knee OA [7].
In another systematic review Kloppenburg and colleagues
examined associations between MRI features and knee
pain, but not structural pathology [14].
We therefore wished to comprehensively review the
literature on subchondral bone structure assessed with all
non-conventional radiographic imaging modalities, exam-
ining the common sites of peripheral OA and describing
the relationships between imaging-detected subchondral
bone features and joint replacement, structural progres-
sion and pain.Fig. 1 Search strategy results and article exclusion. *Two articles included b
16 case–control studies and 55 cohort studiesMethods
Systematic literature search
A systematic literature search of Medline (from 1950),
EMBASE (from 1980) and the Cochrane library databases
until September 2014 was performed. A full description of
the search terms used is recorded in Additional file 1:
Table S1. An abbreviation of the full search terms used
was ‘knee, hip, hand, foot and ankle’ and ‘osteoarthritis’
and ‘subchondral bone’ manifestations of OA (‘bone
marrow lesion’, ‘osteophyte’, ‘bone cyst’, ‘bone area’, ‘bone
shape’, ‘bone attrition’, bone morphometry and mineral
density) and ‘MRI’ or ‘CT’ or ‘DXA’ or ‘scintigraphy’ or
‘PET’. The search term ‘bone shape’ was not restricted
to non-conventional radiographic imaging. The final search
was restricted to humans. There was no language restric-
tion and abstracts were not excluded. Exclusion criteria are
listed in Fig. 1. Any analysis of fewer than 20 patients with
confirmed OA was excluded to remove papers at risk of
study imprecision. The inclusion criteria were in vivo ob-
servational studies of a human population with clinicaloth cross-sectional and longitudinal data. Longitudinal data included
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scription of the adjacent subchondral bone pathology to
the osteoarthritic joint and the relationship of this with
pain, structural progression or joint replacement. Ana-
lyses describing the relationship between OA bone
manifestations and structural severity (cross-sectional)
or progression (prospective cohorts) in populations with-
out clinical and radiographic OA were included to incorp-
orate early structural features of joint degeneration. The
outcome measures of structural severity or progression
included cartilage defects, cartilage thickness, cartilage
volume, denuded subchondral bone, Kellgren-Lawrence
(KL)grade, joint space width and joint space narrowing.
Other outcome measures included joint replacement and
any pain measures.
The articles identified by the preliminary search were
screened by two reviewers (DH, AB) for relevance and for
references not identified by the preliminary search, al-
though no additional citations were found. Discordance in
opinion was resolved by a third reviewer (SK). We applied
the methods for reporting meta-analyses of observational
studies in epidemiology that are recommended by the
Cochrane collaboration [15, 16].
Data extraction
Data extraction was performed by two reviewers (DH, AB)
as described in the Supplementary methods ‘data extrac-
tion’ (see Additional file 1).
Quality assessment
The quality of each observational study was independently
assessed by two reviewers (TC, AB), as described in Sup-
plementary methods ‘Quality assessment’ (see Additional
file 1).
Best evidence synthesis
Statistical pooling of the data was considered inappropriate
in light of the heterogeneous study populations, methodo-
logical quality and bone feature or outcome measurements
for OA. Therefore a qualitative summary of the evidence
for each bone feature (e.g., BML) and its association with
pain or structural progression and joint replacement
was provided based on the study design, adequacy of adjust-
ment for confounders (age, body mass index and gender)
and quality score as described in the Supplementary
methods ‘Best evidence synthesis’ (see Additional file 1).
Studies that investigated the association between multiple
bone features and OA pain or structural progression
outcomes were considered as a single study for each bone
feature. Included studies that established significant cor-
relation between bone and pain, structural progression
or joint replacement were described as positive (+) or
negative (−) accordingly. If no association or inconclusivefindings were described this was reported as no associ-
ation (NA) or no conclusion (NC) respectively.Results
Systematic literature search and selection
The Preferred reporting items for systematic reviews and
meta-analyses (PRISMA) diagram in Fig. 1 describes the
literature flow. Following exclusion of duplicates and
triplicates, 2,456 articles met the search criteria. After
applying inclusion/exclusion criteria, 139 articles were
included for data extraction and quality scoring. In total,
71 papers provided longitudinal data (55 cohorts, 16
case−controls), 70 provided cross-sectional data, and two
papers provided both.Data extraction from selected studies
In only 12 studies did the mean age fall below 50 years
[17–29]. Most (n = 93) described both genders; 2 studies
included men only [27, 30], 14 studies included female
individuals only [22, 28, 29, 31–41] and there was an un-
disclosed gender ratio in 6 [42–50]. Knee OA was defined
using clinical and radiographic criteria and is described in
Additional file 1: Table S6. Radiographic OA was in-
variably defined as KL grade ≥2 or any radiographic
OA abnormality from the Altman atlas [51]. Individual
pain or structural progression measures were examined
in 88 studies; 52 studies examined multiple features.
Subchondral bone was analyzed with MRI in 113 articles,
DXA in 8 [30–32, 42, 52–55], CT in 4 [33, 40, 56, 57], and
scintigraphy in 8 [24, 37, 38, 58–62], and no articles
using PET met the inclusion criteria. Included articles
described 116 knee, 15 hip, 6 hand and 2 ankle studies.
Of these studies 13 described structural associations
without clinical or radiographic OA [18, 19, 23, 25, 26,
35, 63–69]. There were no articles on studies of the
foot that met the inclusion criteria.Quality assessment of studies
Concordance of opinion in quality scoring was observed
in 2,040 (89 %) of the 2,242 scoring items assessed, which
are recorded in Additional file 1: Tables S3-S5. The major-
ity of discordant scoring was for study design (criteria 17)
and data presentation (criteria 18). Quality scores were
converted to percentages of the maximum scores for
each class of paper. The mean (range) quality score was
59 % (29–79), 54 % (22–83) and 59 % (47–76) for cross-
sectional, cohort and case–control studies, respectively.Relationship between knee bone feature and structural
progression
The association of bone features with structural progres-
sion and joint replacement are described in Tables 1 and 5.
Table 1 Knee structural associations by feature and quality grade
Author Feature (method) Structural progression
outcome
Adjustment for
confounders
Association (magnitude)
crude
Association (magnitude)
adjusted
Association Quality
(score %)
MRI bone marrow lesion - cohorts
Felson 2003 [70] Baseline presence of BML
in medial or lateral TFJ (C)
OARSI JSN grade
progression of
TFJ (L)
Age, sex, and BMI NR OR 6.5, + High (83)
95 % CI 3.0 to 14.0
Dore 2010 [124] Baseline semi-quantitative
MRI BML size (C) TFJ
Incident TKR over
5 years (L)
Age, sex, BMI, knee
baseline pain, leg
strength, cartilage
defects, tibial bone
area, ROA
OR (95 % CI) OR (95 % CI) + High (64)
2.04 (1.55 to 2.69) 2.10 (1.13 to 3.90)
p <0.01 p = 0.019
Driban 2013 [72] Knee baseline BML
volume (C)
48-month change in
OARSI JSN grade (L)
Age, sex, BMI NR Baseline BML volume + High (61)
OR 1.27, 95 % CI 1.11
to 1.46
BML volume 48 month
change (L) (TFJ)
(TFJ) BML volume regression
OR 3.36, 95 % CI 1.55
to 7.28
Davies-Tuck
2010 [67]
Incident BML (new BML
after 2 years with no BMLs
at baseline) MRI TFJ (L)
Progression in semi-
quantitative MRI
cartilage defects score
after 2 years. TFJ (L)
Age, gender, BMI,
baseline cartilage
volume
OR (95 % CI) OR (95 % CI) + High (61)
Medial TFJ Medial TFJ Association in the
lateral TFJ and a
trend in the medial
TFJ
1.86 (0.70 to 4.93) p = 0.21 2.63 (0.93 to 7.44)
p = 0.07
Lateral TFJ Lateral TFJ
3.0 (1.01 to 8.93) p = 0.05 3.13 (1.01 to 9.68)
p = 0.05
Hochberg 2014 [44] Semi-quantitative MRI
baseline femoral condyle
BML size (C)
Incident TKR over
6 years (L)
Age, gender, BMI,
race, marital status,
depressive symptoms,
quality of life, mechanical
pain, KL grade, clinical
effusion.
Medial TFJ Medial TFJ + High (61)
p <0.0001 p = 0.02
Raynauld 2011 [75] Baseline semi-quantitative
BML score (C) TFJ
Incidence of TKR over
3 years (L)
Age, sex, BMI, JSW,
WOMAC,
NR OR (95% CI) + High (61)
BML medial plateau
1.81 (1.08 to 2.03)
p = 0.025
Raynauld 2013 [74] Baseline semi-quantitative
BML WORMS score (C)
medial TFJ
Incident TKR (L)
4 year follow up
Age, BMI, gender
WOMAC, CRP
NR TKR incidence + High (61)
OR (95 % CI) 2.107
(1.26 to 3.54) p = 0.005
time to TKR incidence
hazard ratio (95% CI)
2.13 (1.38 to 3.30)
p = 0.001
Time to TKR (L)
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Table 1 Knee structural associations by feature and quality grade (Continued)
Crema 2014 [71] MRI BML (semi-quantitative) Cartilage loss (semi-
quantitative)
Age, gender, BMI NR β = 0.37 to 0.64
p <0.001
+ High (56)
(C) all regions (L) (all regions)
Guermazi 2014
Abstract [73]
Baseline semi-quantitative
BML score WORMS (C)
Cartilage thickness loss
over 30 months (L)
Age, sex, body mass
index, and anatomical
alignment axis (degrees)
NR Combined BML score
in the medial and
lateral TFJ compartment
+ High (56)
OR 1.9, 95 % CI 1.1
to 3.3
Scher 2008 [87] Presence of any baseline
semi-quantitative MRI
BMLs (C)
Incident TKR (L) over
3 years
Age NR OR (95 % CI) + High (56)
8.95 (1.49 to 53.68)
p = 0.02
Sowers 2011 [28] Semi-quantitative MRI
BML, size in TFJ (C)
Progression in KL
grade
Nil R (95 % CI) medial tibia ~
0.46 (0.35 to 0.55)
NR + Low (53)
(11-year follow up) (L) Lateral tibia ~0.23 (0.13
to 0.33)
Kothari 2010 [82] Semi-quantitative baseline
MRI BML, (WORMS) (C) TFJ
Semi-quantitative
cartilage defect score
change over 2 years
(WORMS) (L) TFJ.
Age, sex, BMI, other bone
lesions
OR 4.04, OR 3.75, + Low (50)
95 % CI 2.25 to 7.26 95 % CI 1.59 to 8.82
Raynauld 2008 [85] Change in BML size (mm)
at 24 months in medial TFJ (L)
Medial cartilage
volume (L) at 24
months in medial TFJ
Age, gender, BMI,
meniscal extrusion
and tear, pain and
bone lesions at baseline
NR Change in BML size
with femoral cartilage
volume loss
- Low (50)
Larger medial BML
size means more
cartilage loss in
medial compartment
β = −0.31
standard error (0.08)
p = 0.0004
Roemer 2009 [90] Change in MRI semi-
quantitative BML size
(WORMS) (L) TFJ and PFJ
Progression in semi-
quantitative cartilage
defects in (WORMS)
over 30 months (L) TFJ
and PFJ
Age, sex, BMI, baseline
KL grade
NR OR (95 % CI) + Low (50)
Incident BML OR 3.5
(2.1 to 5.9)
Progression of BML
2.8 (1.5 to 3.2)
Resolution of BML OR
0.9 (0.5 to 1.6)
Stable BML OR 1.0
(reference)
Dore 2010 [76] Baseline semi-quantitative
BML severity (C) (medial
and lateral TFJ)
Ipsi-compartmental
annual Cartilage
volume loss (L)
Age, sex, BMI, meniscal
damage
NR Baseline - Low (50)
BML severity Bigger BML means
bigger volume loss
β = −22.1 to −42.0,
for all regions
(p <0.05)
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Table 1 Knee structural associations by feature and quality grade (Continued)
Parsons 2014
Abstract [83]
Baseline semi-quantitative
BML score (C)
Annual TFJ JSN (L) Age, sex, baseline KL
grade
NR β = −0.10, 95 % CI + Low (50)
−0.18 to
−0.02
Wildi 2010 [95] 24-month regional
change in TFJ BML
score WORMS (L)
24-month regional
change in cartilage
volume (L)
nil R correlation coefficients
all <0.07
NR NC Low (50)
p >0.367 for all three
compartments at 24
months
Pelletier 2007 [84] Regional Semi-quantitative
baseline BML score (medial
or lateral TFJ) (C)
Regional cartilage
volume over 24
months (medial
or lateral TFJ) (L)
NR Lateral compartment BML
score
NR Low (50)
β = −0.31, p = 0.001
Driban 2011 [79] Baseline BML volume (C)
and 24 month change in
BML volume (L) in TFJ
compartments
24-month change in
full thickness cartilage
lesion area (L)
Age, sex, body mass
index
NR Baseline BML volume
r = 0.48, 95 % CI 0.20
to 0.69
+ Low (50)
Baseline femur BML
volume with loss in
ipsicompartmental
full thickness
cartilage lesion area.
p <0.002
Tanamas 2010 [89] Baseline semi-quantitative
MRI BML size (C) TFJ
Cartilage volume
change over 2 years
(L) TFJ Incident TKR
over 4 years
Age, sex, BMI, baseline
tibial cartilage volume
and bone area
R (95 % CI) R (95 % CI) + Low (50)
Total cartilage loss Total cartilage loss
0.61 (−0.11 to 1.33) 1.09 (0.24, 1.93)
OR (95 % CI) OR (95 % CI)
Incident TKR Incident TKR
1.55 (1.04 to 2.29) 1.57 (1.04 to 2.35)
p = 0.03 p = 0.03
Madan-Sharma
2008 [93]
Baseline MRI semi-
quantitative BML (C) TFJ
OARSI medial TFJ JSN
grade progression
over 2 years (L) TFJ
Age, sex, BMI, family
effect
NR 0.9 RR, NA Low (47)
95 % CI 0.18 to 3.0
Tanamas 2010 [88] Semi-quantitative change
in MRI BML severity (C)
Incident TKR over
4 years (L)
Age, gender, KL grade OR (95 % CI) OR (95 % CI) + Low (47)
Medial TFJ Medial TFJ Association in the
medial TFJ but not
in the lateral TFJ1.72 1.99
(0.93 to 3.18) (1.01 to 3.90)
p = 0.08 p = 0.05
Lateral TFJ Lateral TFJ
0.95 (0.48 to 1.88) 0.96 (0.48 to 1.94)
p = 0.89 p = 0.91
Roemer 2012 [86] Semi-quantitative BML
(WORMS) TFJ and PFJ (C)
Semi-quantitative
cartilage score
Age, sex, treatment, and
BMI.
NR BML TFJ OR 4.74, 95 %
CI 1.14 to 19.5
+ Low (44)
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Table 1 Knee structural associations by feature and quality grade (Continued)
6-month progression
TFJ and PFJ (L)
p = 0.032 BMLs and cartilage
score correlate
BML PFJ OR, 1.63 (0.67
to 3.92)
Crema 2013 [78] MRI incident BML (WORMS) Progressive (30
month) semi-
quantitative
cartilage defect
(WORMS) TFJ (L)
Age, sex, BMI, malalignment,
meniscal disease
NR OR (95 % CI) + Low (44)
TFJ Medial TFJ 7.6
(L) (5.1 to 11.3)
Lateral TFJ
11.9 (6.2 to 23.0)
Hernandez-Molina
2008 [81]
Crude presence of central
BMLs on MRI (C) TFJ
Semi-quantitative
cartilage defect
(WORMS) (L) TFJ
Alignment, BMI, KL grade,
sex, and age.
NR Medial TFJ cartilage
loss
+ Low (44)
OR 6.1,
95 % CI 1.0, 35.2
Koster 2011 [25] Baseline BML presence
(C) TFJ
Any progression in
KL grade over 1 year
(L) TFJ
Age, BMI OR (95 % CI) OR (95 % CI) + Low (44)
6.01 (1.92 to 18.8) 5.29 (1.64 to 17.1)
p = 0.002 p = 0.005
Hunter 2006 [91] Change in MRI semi-
quantitative BML score
(L) TFJ
Change in semi-
quantitative cartilage
defect score (WORMS)
(L) medial or lateral
TFJ
Limb alignment Ipsilateral cartilage loss Ipsilateral cartilage
loss
NA after adjustment Low (44)
β = 0.65 β = 0.26
p = 0.003 p = 0.16
Contralateral cartilage
loss
Contralateral cartilage
loss
β = −0.27 β = −0.16
p = 0.22 p = 0.52
Roemer 2009 [94] Baseline MRI BML crude
presence or absence
(WORMS) (L) TFJ
Semi-quantitative
cartilage defect
progression over 30
months (WORMS)
(L) TFJ
Age, sex, race, BMI,
alignment
OR (95 % CI) OR (95 % CI) NA Low (44)
Slow cartilage loss OR
1.74 (0.85 to 3.55)
Slow cartilage loss OR
1.79 (0.83 to 3.87)
Fast cartilage loss OR
1.32 (0.37 to 4.78)
Fast cartilage loss OR
1.0 (0.24 to 4.10)
Kubota 2010 [92] MRI BML semi-quantitative
volume score change over
6 months (L) TFJ
KL grade progression
over 6 months (L) TFJ
Nil BML score higher in KL
progression group
NR NC Low (39)
p = 0.044
Driban 2012
abstract [80]
MRI BML volume change
(L) TFJ over 24 months
Change in cartilage
thickness and
denuded area of bone
(L) TFJ over 24 months
Nil Cartilage thickness NR + Low (28)
r = −0.34, p = 0.04
denuded bone
r = 0.42, p = 0.01
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Table 1 Knee structural associations by feature and quality grade (Continued)
Femoral cartilage indices
p >0.05
Carrino 2006 [77] Crude presence of MRI
BML, TFJ (C) and (L)
Any grade of cartilage
defect TFJ (C) and (L)
Nil NR NR + Low (22)
MRI bone marrow lesion - cross-sectional studies
Baranyay 2007 [63] MRI BML defined as large
or not large/absent in the
medial and lateral
compartments of TFJ (C)
MRI semi-quantitative
cartilage defects of
medial and lateral
compartments of
TFJ (C)
Age, gender, BMI, cartilage
volume or bone area
OR (95 % CI) OR (95 % CI) + High
(71 %)
Quantitative cartilage
volume medial and
lateral TFJ (C)
Cartilage defect Medial
TFJ
Cartilage defect Medial
TFJ
Cartilage defects
1.81 (1.26 to 2.59)
p = 0.005
1.80 (1.21 to 2.69)
p = 0.004
NA
Lateral TFJ Lateral TFJ Cartilage volume
1.52 (1.14 to 2.04) 1.45 (1.02 to 2.07)
p = 0.005 p = 0.04
No association with
ipsicompartmental
cartilage volume
No association with
ipsicompartmental
cartilage volume
Guymer 2007 [35] Presence or absence of
MRI BMLs
Presence or absence
of semi-quantitative
cartilage defects
Age, height, weight, and
tibial cartilage volume
OR (95 % CI) OR (95 % CI) + High (71)
(C) TFJ (C) TFJ
Medial TFJ Medial TFJ A positive association
is observed in the
medial but not the
lateral TFJ
6.46 (1.04 to 38.39) 3.51 (1.08 to 11.42)
p = 0.04 p = 0.04
Lateral TFJ Lateral TFJ
1.17 (0.22 to 6.26) 1.02 (0.17 to 6.12)
p = 0.85 p = 0.98
Stehling 2010 [65] Presence of any MRI semi-
quantitative BMLs (C)
Presence of any
WORMS MRI cartilage
defects (C)
Age, gender and BMI, KL
score, knee injury or knee
surgery, family history of
TKR and Heberden's nodes
NR p <0.0001 + High (71)
Torres 2006 [103] MRI BML (WORMS) (C)
TFJ and PFJ
Semi-quantitative
cartilage (WORMS) (C)
Nil R = 0.56 NR + High (68)
Ip 2011 [99] Semi-quantitative MRI
BML (C)
KL grade (C) Age, sex, BMI, OA stage,
joint effusion, and meniscal
damage
NR Highest BML score
p <0.001
+ High (68)
Hayes 2005 [22] Semi-quantitative MRI
BML (C)
KL grade (C) Nil p = 0.005 NR + High (61)
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Table 1 Knee structural associations by feature and quality grade (Continued)
Kornaat 2005 [100] Semi-quantitative MRI
BML (KOSS)
Semi-quantitative
cartilage defects
(KOSS) TFJ and PFJ (C)
Nil OR (95 % CI) NR + Low (57)
PFJ
TFJ and PFJ (C) 17 (3.8 to 72)
TFJ
120 (6.5 to 2,221)
Gudbergsen 2013
[98]
Semi-quantitative MRI
BML (BLOKS) (C)
KL grade (C) Nil KL grade NR + Low (57)
p = 0.046 lateral
p <0.001 medial
Link 2003 [101] Semi-quantitative MRI
BML, (C)
KL grade (C) Nil p <0.05 NR + Low (54)
Sowers 2003 [29] Semi-quantitative MRI
BML (C)
Semi-quantitative
cartilage defect (C)
Nil p for trend NR + Low (54)
p <0.0001
Felson 2001 [96] Semi-quantitative MRI
BMLs (C)
KL grade (C) Nil NR NR + Low (54)
Lo 2005 [102] Semi-quantitative MRI
BML (WORMS ≥ 1) (C)
KL grade ≥ 2 (C) Nil NR NR + Low (50)
Meredith 2009 [64] Sum of semi-quantitative
MRI
Sum of semi-
quantitative MRI
Nil p <0.0003 NR + Low (50)
BML scores in the TFJ
and PFJ (C)
Cartilage defect scores
in the TFJ and PFJ (C)
Fernandez-Madrid
1994 [97]
Crude presence of MRI
BMLs (C)
KL grade (C) Nil p <0.001 NR + Low (46)
Scher 2008 [87] Semi-quantitative MRI
BML (C)
Semi-quantitative
cartilage defect
(modified Noyes) (C)
Nil p = 0.012 NR + Low (43)
MRI bone marrow lesion - case control studies
Ratzlaff 2014 [104] Total tibial BML volume 12
and 24 months before TKR
and interval change
between 12 and 24 (C)
and (L) TFJ
Incident TKR (L) NB matched cases and
controls
OR (95 % CI) NR + High (65)
12 months (C) True of TFJ but not
PFJ
1.68 (1.33 to 2.13)
24 months (C)
1.35 (1.02 to 1.78)
12 to 24 months
change (L)
1.23 (1.03 to 1.46)
Zhao 2010 [105] Baseline crude presence
of MRI BMLs at (C) TFJ
Overlying cartilage
defect progression
after 1 year (WORMS)
(L) TFJ
Nil Change in cartilage
defect scores for areas
with and without
underlying BMLs
NR + Low (56)
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Table 1 Knee structural associations by feature and quality grade (Continued)
p = 0.00003
Aitken 2013
Abstract [17]
Semi-quantitative BMLs
tibia, femur and patella
Cartilage volume and
defect score tibia and
femur
Age, sex, BMI NR Tibial cartilage volume - Low (47)
β = −433 mm3 per
unit increase in BML
p <0.01
Stahl 2011 [41] Semi-quantitative MRI BML
size (WORMS) (L) TFJ
Semi-quantitative
cartilage defect size
(L) TFJ
Nil NR p <0.165 NA Low (47)
MRI osteophyte - cohort studies
De-Lange 2014
abstract [106]
Semi-quantitative
osteophyte (KOSS) (C)
Radiographic
progression of JSN
of TFJ (L)
Age, gender, BMI and
baseline JSN
NR OR (95 % CI) + High (61)
1.8 (1.1 to 3.1) Higher OST score,
the higher the JSN
Liu 2014
Abstract [45]
Baseline semi-quantitative
osteophyte score (WORMS)
(C) TFJ
Incident TKR at
6-months follow
up (L)
Activity of daily living
disability score
NR RR (95 % CI) 3.01 (1.39
to 6.52)
+ Low (50)
Sowers 2011 [28] Semi-quantitative MRI
osteophyte size in TFJ (C)
Progression in KL
grade (11-year follow
up) (L)
Nil R (95 % CI) medial tibia ~
0.65 (0.59 to 0.71)
NR + Low (53)
Lateral tibia ~0.57 (0.49
to 0.63)
MRI osteophyte - cross-sectional studies
Stehling 2010 [65] Presence of any MRI semi-
quantitative osteophytes (C)
Presence of any
WORMS MRI cartilage
defects (C)
Age, gender and BMI, KL
score, knee injury or knee
surgery, family history of
TKR and Heberden’s nodes
NR p = 0.0037 + High (71)
Torres 2006 [103] MRI osteophyte, (WORMS)
TFJ and PFJ (C)
Semi-quantitative
cartilage (WORMS)
TFJ and PFJ (C)
Nil R = 0.73 NR + High (68)
Hayes 2005 [22] Semi-quantitative MRI
osteophyte (C)
KL grade (C) Nil p <0.001 NR + High (61)
Meredith 2009 [64] Sum of semi-quantitative
MRI
Sum of semi-
quantitative MRI
Nil p <0.0001 NR + Low (50)
Osteophyte scores in the
TFJ and PFJ (C)
cartilage defect scores
in the TFJ and PFJ (C)
McCauley 2001 [26] MRI central osteophyte
presence (C) TFJ
MRI cartilage lesion
presence (C) TFJ
Nil Crude association of 32
of 35 central osteophytes
having adjacent cartilage
lesions
NR + Low (29)
Crude, unadjusted
Roemer 2012 [108] MRI osteophyte Cartilage defect
(WORMS) (C)
Age, sex, BMI, race, TFJ
radiographic OA
OR 2378.1, OR 108.8, + Low (57)
95 % CI 249.8 to 22643.4 95 % CI 14.2 to 834.9(WORMS) (C)
p for trend <0.0001
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Table 1 Knee structural associations by feature and quality grade (Continued)
Link 2003 [101] Semi-quantitative MRI
osteophytes (C)
KL grade (C) Nil p <0.01 NR + Low (54)
Fernandez-Madrid
1994 [97]
Crude presence of MRI
osteophytes (C)
KL grade (C) Nil p <0.001 NR + Low (46)
MRI bone attrition - cohort studies
Kothari 2010 [82] Semi-quantitative baseline
MRI attrition
Semi-quantitative
cartilage defect score
change over 2 years
(WORMS) (L) TFJ.
Age, sex BMI, other bone
lesions
OR 3.17, OR 1.85, NA Low (50)
95 % CI 1.64 to 6.16 95 % CI 0.71 to 4.82
(WORMS) (C) TFJ
MRI bone attrition - cross-sectional studies
Torres 2006 [103] MRI attrition (WORMS) TFJ
and PFJ (C)
Semi-quantitative
cartilage (WORMS)
TFJ and PFJ (C)
Nil R = 0.75 NR + High (68)
Reichenbach
2008 [110]
Semi-quantitative MRI bone
attrition (WORMS) (C)
KL grade and semi-
quantitative cartilage
defects (WORMS) (C)
Nil NR NR + Low (43)
Crude correlation
MRI bone attrition - case control studies
Neogi 2009 [109] Baseline semi-quantitative
MRI bone attrition size
(WORMS) (C) TFJ
Cartilage defects
progression (WORMS)
after 30 months TFJ
Age, sex, BMI OR 5.5, OR 3.0, + Low (59)
95 % CI 3.0 to 10.0 95 % CI 2.2 to 4.2
MRI bone Shape/dimension – cohort studies
Cicuttini 2004 [111] Baseline quantitative MRI
tibial bone area (C)
TKR incidence (L) over
4 years
Age, sex, height, weight,
BMI, WOMAC, ROA severity
NR OR (95 % CI) + High (78)
1.2 (1.0 to 1.4)
p = 0.02
Ding 2008 [20] Baseline MRI tibial bone
area (C) TFJ
Progressive cartilage
volume loss (L) TFJ
Age, sex, BMI, OA family
history, muscle strength
and ROA.
β (95 % CI) β (95 % CI) - High (72)
Medial femoral cartilage Medial femoral cartilage
β = 0.17 (0.04 to 0.29) β = 0.35 (0.14 to 0.56)
Total femoral cartilage Total femoral cartilage
β = 0.07 β = 0.13
(0.003 to 0.14) (0.02 to 0.25)
Ding 2006 [18] Baseline MRI tibial bone
area (C) TFJ
Change in semi-
quantitative MRI
cartilage defect scores
over 2.3 years (L) TFJ
Age, sex, BMI, radiographic
OA \features
NA OR (95%CI) - High (61)
Medial TFJ
1.24 (1.01 to 1.51)
p = 0.04
Lateral TFJ
2.07 (1.52 to 2.82)
p <0.001
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Table 1 Knee structural associations by feature and quality grade (Continued)
Everhart 2014 [114] Baseline TFJ subchondral
surface ratio of medial and
lateral TFJ compartments
(C)
Radiographic
progression of lateral
or medial TFJ knee
OA at 48 months (L)
Sex, race, age, BMI, tobacco
use, activity level, knee
coronal alignment, baseline
symptoms, injury history,
surgery history, KL grade,
and JSW
Unadjusted medial SSR
vs progression of medial
JSN
Neither medial nor
lateral SSR was
associated lateral
or medial ROA
progression in
adjusted analysis
p <0.05.
NA High (61)
OR 1.43, 95 % CI 1.15
to 1.77
p = 0.0015
Medial SSR vs progression
of lateral JSN
OR 1.87, 95 % CI 1.44
to 2.42
p <0.001
Davies-Tuck
2008 [112]
Baseline MRI tibial bone
plateau area (C) TFJ
Progressive semi-
quantitative cartilage
defect score (L) medial
and lateral TFJ
Age, sex, BMI, baseline
cartilage defect score,
baseline cartilage volume
and baseline tibial plateau
area
Lateral TFJ OR (95 % CI) + High (56)
OR (95 % CI) −0.01 (−0.06
to 0.03) p = 0.59
Lateral TFJ 0.06 (0.004
to 0.11) p = 0.03
Medial TFJ 0.07 (0.03
to 0.12) p = 0.002
Carnes 2012 [113] MRI tibial bone area (C) Semi-quantitative
cartilage defect
progression TFJ (L)
Age, sex, BMI, cartilage
defects, BML
Lateral tibial bone area OR
1.11, 95 % CI 1.0 to 1.23
OR (95 % CI) bone
area medial 1.12 (1.01
to 1.26) and lateral
tibial (1.35 (1.12 to
1.63)
+ Low (50)
Dore 2010 [68] Baseline tibial bone area
MRI (C)
Increase or no increase
in semi-quantitative
MRI tibial cartilage
defects over 2.7 years
(L)
Age, sex, body mass index,
baseline cartilage defects,
and subchondral bone
mineral density
NR OR (95 % CI) medial
tibia 1.6 (1.0 to 2.6)
p = 0.04 lateral tibia
2.4 (1.4 to 4.0) p <0.01
+ Bone area size is
associated with
increasing cartilage
defect scores
Low (50)
Hudelmaier 2013
[180] Abstract
Annual change in
segmented MRI knee
bone area (L)
Baseline KL grade (C) Nil Medial tibia p <0.05 NR + The higher the KL
grade the larger the
increase in bone area
Low (50)
MRI bone shape/dimension - cross-sectional studies
Ding 2005 [19] MRI quantitative tibial
bone area (C)
Semi-quantitative MRI
knee cartilage defect
severity scores (C) TFJ
Age, sex, BMI, family history,
cartilage volume
β (95 % CI) medial TFJ
0.06 (0.03 to 0.09) lateral
TFJ 0.09 (0.05 to 0.13)
β (95 % CI) medial TFJ
0.11 (0.07 to 0.15)
lateral TFJ 0.17 (0.11
to 0.22)
+ Association
maintained for the
whole TFJ and by
compartment
High (64)
Kalichman
2007 [165]
MRI patellar length ratio,
trochlea sulcus angle (C)
JSN grade (C) Age, sex, BMI NR Trochlea sulcus angle
p for trend, medial
JSN p = 0.0162, lateral
JSN p = 0.1206
NC High (64)
Kalichman
2007 [115]
MRI patellar length ratio,
trochlea sulcus angle (C)
Cartilage defect
(WORMS) (C)
Age, sex, BMI NR Trochlea sulcus angle
p for trend, medial
cartilage loss p =
0.0016, lateral cartilage
loss p = 0.0009
+ Low (57)
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Table 1 Knee structural associations by feature and quality grade (Continued)
Stefanik 2012 [116] MRI lateral trochlear
inclination and trochlear
angle (C)
Semi-quantitative
cartilage defect
(WORMS) (C)
Age, sex, BMI NR Lateral trochlear
inclination OR 2,
95 % CI 1.9 to 3.7,
p <0.0001, trochlear
angle OR 2.0, 95 % CI
1.2 to 3.5, p <0.0001
+ Low (57)
Frobell 2010 [107] MRI bone area - manual
segmentation (C)
KL grade, OARSI JSN
grade (C)
Age and BMI Medial tibia JSN and KL
p <0.0125
Medial tibia JSN and
KL p <0.0125
+ Low (57)
Wang 2005 [66] Annual % change in tibial
bone area (L) 2 years
follow up
Baseline JSN (C) Age, sex, BMI, WOMAC
score, SF-36 score, physical
activity, radiographic OA
features, baseline tibial
plateau bone area.
β (95 % CI) medial tibia
β = 0.35 (−1.10 to 1.80)
p = 0.63, lateral tibia
−0.87 (−2.35 to 0.61)
p = 0.25
β (95 % CI) medial
tibia 1.88 (0.43 to 3.33)
p = 0.01 lateral tibia
−0.42 (−2.31 to 1.48)
p = 0.66
+ Association with
medial tibia but not
in the lateral tibia
Low (57)
Jones 2004 [23] Tibial bone area (MRI) (C) Radiographic JSN (C) Age, sex, height, weight β (95 % CI) medial tibia
β = −0.03 (−0.11 to 0.06),
lateral tibia −0.00 (−0.07
to 0.06)
β (95 % CI) medial
tibia β = −0.00 (−0.04
to 0.06), lateral tibia
+0.00 (−0.04 to 0.05)
NA Low (50)
Eckstein 2010 [117] MRI tibial bone area
(segmented) (C)
OARSI JSN grade (C) Nil p <0.01 NR + Low (43)
MRI bone shape/dimension - case–control studies
Bowes 2013 [118] Change in segmented
MRI 3D bone area over
4 years (L)
KL grade defined ROA
knee (C) and (L)
Nil NR bone area increased
significantly faster in ROA
vs non-ROA p <0.0001
NR + Higher KL grades
had greater increase
in bone area,
High (71)
Neogi 2013 [120] MRI 3D bone shape (tibia,
femur and patella) (C)
Incident TFJ ROA KL
grade ≥2 (L)
Age, sex, BMI NR OR 3, 95 % CI 1.8 to 5.0 + Developing 3D
OA knee shape is
associated with
increasing ROA knee
High (65)
Hunter 2013
abstract [119]
Change in MRI knee bone
area over 24 months (L)
Incident TFJ ROA (KL
grade ≥2) (L)
NR NR Hazard ratio (95 % CI)
range from 1.17 (1.08
to 1.27) to 3.97 (2.38
to 6.63), all highly
statistically significant
+ for all bone
regions Enlarging
bone area associated
with increasing ROA
knee
Low (59)
Wluka 2005 [121] Change in MRI tibial bone
area (L)
Baseline radiographic
JSN (C)
Age, BMI, pain, physical
activity
Medial tibial bone area
R = 160, 95 % CI 120 to
201, p <0.001
Medial tibial bone
area R = 145, 95 % CI
103 to 186, p <0.001
+ Low (47)
MRI bone cyst - cohort studies
Kotharii 2010 [82] Semi-quantitative baseline
MRI bone cyst (WORMS)
(C) TFJ
Semi-quantitative
cartilage defect score
change over 2 years
(WORMS) (L) TFJ.
Age, sex BMI, other bone
lesions
OR 1.66, 95 % CI 0.55
to 4.99
OR 0.47, 95 % CI 0.11
to 2.03
NA Low (50)
Tanamas 2010 [88] Semi-quantitative change
in MRI bone cyst size (L)
Knee Cartilage volume
loss over 2 years (L)
TFJ
Nil β (95 % CI) lateral tibial
cartilage loss in cyst
regression relative to
stable and progressive
cysts
NR + Low (47)
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Table 1 Knee structural associations by feature and quality grade (Continued)
β = −11.81 (−16.64
to −6.98)
Madan-Sharma
2008 [93]
Baseline MRI semi-
quantitative bone cyst
(C) TFJ
OARSI medial TFJ JSN
grade progression
over 2 years (L) TFJ
Age, sex, BMI and family
effect
NR RR 1.6, 95 % CI 0.5 to
4.0
NA Low (47)
Carrino 2006 [77] Crude presence of MRI
bone cyst TFJ (C) and (L)
Any grade of cartilage
defect TFJ (C) and (L)
Nil NR NR + Low (22)
MRI bone cyst -– cross-sectional studies
Stehling 2010 [65] Presence of any MRI semi-
quantitative cyst (C)
Presence of any
WORMS MRI cartilage
defects (C)
Age, gender and BMI, KL
score, knee injury or knee
surgery, family history of
TKR and Heberden’s nodes
NR p = 0.0131 + High (71)
Torres 2006 [103] MRI bone cyst (WORMS)
TFJ and PFJ (C)
Semi-quantitative
cartilage (WORMS)
TFJ and PFJ (C)
Nil R = 0.75 NC High (68)
Hayes 2005 [22] Semi-quantitative MRI bone
cyst (C)
KL grade (C) Nil p = 0.02 NR + High (61)
Link 2003 [101] Crude presence of MRI
bone cyst (C)
KL grade (C) Nil p <0.01 NR + Low (54)
Crema 2010 [122] MRI Bone cysts
(WORMS) (C)
Cartilage defect
(WORMS) (C)
Nil NR NR + Low (50)
CT bone cyst – cross-sectional studies
Okazaki 2014 [40] Number of CT bone cysts
(medial femur and tibia) (C)
Knee KL grade (C) Nil p <0.05 Nil +with KL grade in
medial TFJ
Low (50)
MRI subchondral bone morphometry - cohort studies
Lo 2012
Abstract [53]
MRI BVF, trabecular number,
thickness and spacing (C)
OARSI medial TFJ JSN
progression between
24 and 48 months (L)
Nil OR 2.4, 95 % CI 1.1 to
5.0, p = 0.02
NR BVF, trabecular
number and
thickness are
positively associated
with JSN progression
but negatively
associated with
trabecular spacing.
Low (50)
MRI subchondral bone morphometry - cross-sectional studies
Driban 2011
[50] Abstract
MRI bone volume fraction,
trabecular number, spacing
& thickness of medial tibia
(C)
The presence of any
grade of radiographic
medial & lateral JSN
(C)
Nil R = 0.09 to 1.77 NR + Medial JSN
associated with higher
BVF, trabecular
number and thickness
but lower spacing
High (71)
Driban 2011 [49] MRI bone volume fraction
(C)
Radiographic JSN (C) Nil NR NR + Higher JSN score,
lower JSW) were
associated with
higher BVF
High (64)
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Table 1 Knee structural associations by feature and quality grade (Continued)
Lindsey 2004 [123] MRI bone volume fraction
trabecular and trabecular
number (TFJ) (C)
Cartilage volume of
tibia or femur in
contralateral TFJ
compartment (C)
Nil Medial TFJ cartilage with
lateral TFJ BVF and
trabecular number.
β = 0.29 to 0.36,
p = 0.0020 to 0.02
NR + With contralateral
BVF and trabecular
number, but – with
trabecular spacing
High (64)
Lo 2012 [54] MRI bone volume fraction,
trabecular thickness,
number, spacing and DXA
BMD of (proximal medial
tibia) (C)
Radiographic medial
JSN grade (C)
Nil All p <0.0001 Nil + (BV/TV, thickness,
number, BMD)
(spacing)
High (64)
Chiba 2012 [34] MRI bone volume fraction
and trabecular thickness of
the medial & lateral femur
& tibia. (C)
Metric JSW
(radiographic) of the
medial and lateral TFJ
(C)
Nil Bone volume fraction
−0.48 (p <0.001) trabecular
thickness −0.51 (p <0.001)
NR - Low (57)
DXA BMD - cohort studies
Dore 2010 [68] Baseline proximal tibial
BMD, DXA (C)
Increase or no increase
in semi-quantitative MRI
tibial cartilage
defects over 2.7 years
(L)
Age, sex, BMI, baseline
cartilage defects and
subchondral tibial
bone area
NR OR (95 % CI) medial
tibia 1.6 (1.2 to 2.1)
p <0.01 lateral tibia
1.2 (0.9, 1.6) p = 0.19
+ Association only
observed in medial
tibia
Low (50)
Lo 2012
Abstract [53]
DXA-measured
medial:lateral periarticular
BMD (paBMD) (C)
OARSI medial TFJ JSN
progression (L)
Nil OR 8.4, 95 % CI 2.8
to 25.0, p <0.0001
nil + JSN association
with baseline M:L
paBMD
Low (50)
Bruyere 2003 [42] Subchondral tibial bone
BMD (DXA) (C)
Minimum medial JSW
TFJ after one year (L)
Age, sex, BMI, minimum
JSW
NR R = −0.43, p = 0.02 Negative correlation
i.e., lower BMD gives
bigger JSW or less JSN
Low (44)
DXA BMD - cross-sectional studies
Dore 2009 [52] DXA tibial subchondral
BMD (C)
Radiograph JSN grade
and MRI cartilage
defect and volume (C)
Age, sex BMI NR Medial tibial BMD vs
JSN R = 0.11, p <0.01,
defect R = 0.16, p <0.01,
cartilage volume R =
0.12, p = 0.01
+ Higher the BMD
the greater the JSN
and cartilage defects,
High (71)
Lo 2006 [55] DXA medial:lateral BMD
ratio at the tibial plateau (C)
Radiographic JSN
grade (medial and
lateral TFJ) (C)
Age, sex, BMI p <0.0001 NR + With medial JSN, −
with lateral JSN
High (71)
Lo 2012 [54] DXA BMD (proximal medial
tibia) (C)
Radiographic medial
JSN grade (C)
Nil p <0.0001 NR + High (64)
Akamatsu 2014
[31] Abstract
BMD (DXA) (C) (medial
tibia and femoral condyle)
Medial TFJ JSN
(radiographic) (C)
Nil Tibia R = 0.571, p <0.001
femur R = 0.550, p < 0.001
NR + Medial femoral
and tibial condyle
BMD correlated with
medial JSN
Low (57)
Volumetric CT BMD - case control studies
Bennell 2008 [56] KL grade (C) Age, sex, BMI NR p <0.05 NC BMD falls in
posterior tibial
Low (59)
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Table 1 Knee structural associations by feature and quality grade (Continued)
Volumetric BMD in tibial
subchondral trabecular
bone (C)
plateau as KL
increases but
anteriorly increase in
BMD noted
Knee scintigraphic subchondral bone cohort studies
Mazzuca 2004 [37] Baseline late-phase
subchondral bone
scintigraphy (adjusted for
healthy diaphysis uptake)
of the medial tibia and
whole knee (C)
Progression of
minimum JSN of
the medial TFJ from
baseline to 30 months
(L)
Age, BMI, KL grade (NB all
women)
r = 0.22 to 0.30 (p <0.05) r = 0 to 0.08 (p <0.05) NA after adjustment
for covariates
High (56)
Mazzuca 2005 [38] Baseline late-phase
subchondral bone
scintigraphy (adjusted
for healthy diaphysis
uptake) of the medial
tibia and whole knee (C)
Progression of
minimum JSN of
the medial TFJ from
baseline to 30
months (L)
Baseline JSW, treatment
group
NR Coefficient 0.221, 95 %
CI 0.003 to 0.439, p =
0.049
+ The greater the
scintigraphic bone
signal the greater
the JSN
High (56)
Dieppe 1993 [58] Baseline late and or early-
phase subchondral bone
scintigraphy signal (C)
Progression of JSN
by ≥2 mm or knee
operation incidence
after 5 years (L)
Nil p <0.005 NR + Low (50)
Knee scintigraphic subchondral bone cross-sectional studies
Kraus 2009 [59] Ipsilateral late-phase bone
scintigraphy, semi-
quantitative retention
scoring of TFJ (C)
Ipsilateral OARSI scale
of JSN (C)
Age, gender, BMI,
osteophyte OARSI
score, knee alignment
knee symptoms
Coefficient 0.47 to 0.48
(p <0.0001)
Coefficient 0.26 to 0.29
(p = 0.0005 to 0.001)
+ High (71)
McCrae 1992 [62] Late-phase ‘extended bone
uptake’ pattern bone
scintigraphy, presence
around the TFJ (C)
Radiographic JSN
presence (C)
Nil OR 47.3, 95% CI 6.4 to
352, p <0.01
NR + Low (50)
2D knee bone shape – cross-sectional studies
Haverkamp
2011 [36]
2D bone shape knee.
1. Femur and tibial width
2. Elevation of lateral tibial
plateau (C)
1. Presence of diffuse
cartilage defects semi-
quantitative scoring
(MRI). 2. Presence of
ROA knee (KL ≥2) (C)
NB (this is a population
of women only) ROA
models adjusted for age,
BMI; cartilage defect
models adjusted
for KL only
OR (95 % CI) bone width
vs knee ROA 2.03 (1.55
to 2.66) p <0.001 bone
width Presence of diffuse
cartilage defects p <0.001
OR (95 % CI) knee ROA
1.94 (1.44 to 2.62)
p <0.001
+ Wider bones and
elevated tibial plateau
were associated with
the presence of ROA
knee. Cartilage defects
were only associated
with bone width
Low (46)
Positive correlation reported between bone feature and outcome measure (+); negative correlation reported between bone feature and outcome measure (−). BMD bone mineral density, BMI body mass index, BML
bone marrow lesion, BOKS Boston osteoarthritis of the knee study, BLOKS Boston–Leeds osteoarthritis knee score, BVF bone volume fraction, C a feature or outcome described in cross-section, CT computed tomography, DXA
dual-energy x-ray absorptiometry, GARP Genetics, osteoarthritis and progression study, JSN joint space narrowing, JSW joint space width, KL Kellgren-Lawrence, KOSS knee osteoarthritis scoring system, L a feature or outcome
described longitudinally, MAK-2 mechanical factors in arthritis of the knee 2. NC no conclusion could be found for an association between bone feature and outcome measure, SWAN Michigan study of women’s health across
the nation, MOST multicentre osteoarthritis study, MRI magnetic resonance imaging, NA no association. NR not reported, OA osteoarthritis, OAI Osteoarthritis Initiative, OR odds ratio, RR relative risk ratio, SSR subchondral sur-
face ratio TASOAC Tasmanian older adult cohort, TFJ tibiofemoral joint, VAS visual analogue scale, WOMAC Western Ontario and McMaster Universities arthritis index, WORMS whole-organ magnetic resonance imaging score,
CRP C-reactive protein, TKR total knee replacement, OARSI Osteoarthritis Research Society International, PFJ patellofemoral joint, ROA radiographic osteoarthritis
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MRI (31 cohort, 15 cross-sectional, 4 case–control studies):
in prospective cohorts with high- quality, well-adjusted
analyses the presence and increasing size of baseline
BMLs and incidence of BMLs conferred greater odds of
structural progression [67, 70–73]. Similarly increasing
baseline BML size increased the risk of total knee re-
placement (TKR) and expedited the outcome of TKR
[44, 74–76]. The association between BMLs and structural
progression of OA was maintained in cohorts without
clinical features of knee OA [67] and in analyses with
poorer quality or statistical adjustment [25, 28, 76–90].
Only five low quality cohort analyses did not support
these findings [91–95]. All cross-sectional analyses found
positive correlation between BMLs and structural severity
of OA [22, 29, 35, 63–65, 87, 96–103]. Three case–control
analyses found similar associations [17, 104, 105]. In sum-
mary, BMLs are independently associated with structural
progression of OA of the knee and incident TKR.Osteophytes
MRI (three cohorts, eight cross-sectional studies): in one
prospective cohort with high quality and well-adjusted
analysis, the increasing size of osteophytes conferred greater
odds of structural progression of OA [106]. In lower qual-
ity, inadequately adjusted, prospective cohorts, increasing
osteophyte size increased the risk of incident TKR and
structural progression of OA [28, 45]. The increasing
size and presence of osteophytes was associated with
greater structural progression or severity in all included
analyses [22, 26, 28, 45, 64, 65, 97, 101, 103, 106–108].
In summary, osteophytes are independently associated with
knee structural progression and are associated with
TKR incidence.
Bone attrition
MRI (one cohort, two cross-sectional, one case–control
study): one prospective, well-adjusted, but below-average-
quality cohort analysis found an association with baseline
attrition severity and structural progression that became in-
significant after covariate adjustment [82]. The unadjusted
cross-sectional analyses and case–control analysis found
similar associations with structural severity [103, 109, 110].
In summary, bone attrition is associated, but not independ-
ently so, with structural progression.
Bone shape/dimension
MRI (eight cohort, seven cross-sectional, four case–control
studies): in prospective cohorts with high quality well-
adjusted analyses, greater baseline tibial plateau bone
area conferred greater odds of structural progression of
OA and incidence of TKR [18, 20, 111, 112]. The same
association was observed in a lower quality, prospective-cohort, well-adjusted analysis [113] and in a study of the
knee in patients who predominantly had no radiographic
evidence of knee OA [18]. The mismatch ratio of the
femoral and tibial articulating areas was not associated
with structural progression after adjustment [114], but
the trochlear sulcus angle and shape was associated with
cross-sectional patellofemoral structural severity dem-
onstrated on MRI [115, 116]. All cross-sectional [23,
66, 107, 117] and case–control [118–121] analyses of
tibial bone area or 3D knee bone shape found association
with structural severity [23, 66, 107, 117–121]. In summary,
tibial bone area is independently associated with structural
progression of OA of the knee and incidence of TKR.
Bone cyst
MRI and CT (five cohort, five cross-sectional) studies:
two prospective cohorts with well-adjusted but below-
average-quality analyses of cysts reported no association
with structural progression of OA before or after adjust-
ment [82, 93]. Two prospective cohorts with low quality
unadjusted analyses of cysts found an association with
structural progression of OA [77, 88]. Cross-sectional
well-adjusted [65] and unadjusted [22, 40, 101, 122] cyst
analyses found an association with structural severity. In
summary, after covariate adjustment there is no independ-
ent association between cysts and structural progression
of OA.
Trabecular bone morphometry
MRI (one cohort, five cross-sectional studies): one pro-
spective cohort, unadjusted, below-average-quality analysis
reported increasing bone volume fraction, trabecular
number and thickness and decreasing trabecular spa-
cing were associated with structural progression [53].
The same bone changes were associated with structural
severity in cross-sectional unadjusted analyses [34, 49, 50,
54, 123]. In summary, increasing bone volume fraction,
trabecular number, trabecular thickness, and decreasing
trabecular spacing are associated with structural progres-
sion and severity of OA of the knee.
Peri-articular bone mineral density
DXA and CT (three cohort, four cross-sectional, one–
case control study): two prospective cohorts with well-
adjusted but below-average-quality analyses reported that
increasing tibial subchondral BMD is associated with
structural progression of OA [42, 68]. In one prospective
cohort with an unadjusted below-average-quality analysis,
the medial-to-lateral ratio of tibial peri-articular BMD
was associated with structural progression [53]. All cross-
sectional analyses [31, 52, 54, 55], including two that were
well-adjusted [52, 55], reported increasing BMD with
greater structural severity. One well-adjusted analysis using
quantitative CT (qCT) reported higher and lower BMD in
Barr et al. Arthritis Research & Therapy  (2015) 17:228 Page 18 of 36the anterior and posterior tibial plateau, respectively, in
knees of patients with moderate OA relative to asymp-
tomatic controls. In summary, increasing peri-articular
radiographic BMD is associated with structural progres-
sion and severity of OA.
Scintigraphy
Scintigraphy (three cohort, two cross-sectional studies):
prospective cohorts with high quality analyses found greater
late-phase bone signal was associated with structural
progression of OA, with no or inadequate covariate
adjustment [37, 38], but not after adequate covariate
adjustment [37]. A prospective cohort, with below-average-
quality, unadjusted analysis found greater bone signal was
associated with structural progression of OA [58]. Bone sig-
nal was associated with structural severity in well-adjusted
and unadjusted cross-sectional analyses [59, 62]. In
summary, bone scintigraphy signal is associated, but not
independently so, with structural progression of OA.
2D Knee bone shape
One cross-sectional, well-adjusted analysis identified an
association between greater femoral and tibial bone width
and elevating tibial plateau, and greater structural severity
[36]. In summary, 2D bone shape is associated with struc-
tural severity of OA.
Relationship between knee bone feature and pain
The association between bone features and pain is described
in Tables 2 and 5. In all types of study, bone features were
compared with the presence, chronicity and severity of pain.
In longitudinal studies, bone features were also compared
with change in the presence or severity of pain (e.g., change
in Western Ontario and McMaster Universities arthritis
index (WOMAC) pain score). Change in the presence of
pain included developing new frequent pain, [49], or the
resolution of existing pain.
Bone marrow lesions
MRI (9 cohort, 18 cross-sectional, 5 case–control studies):
in 3 prospective cohort, well-adjusted, high quality ana-
lyses the baseline or longitudinal increase in size of
BMLs was associated with longitudinally increasing
knee WOMAC pain severity [21, 72, 124]. This associ-
ation was observed in one [28] but not two [89, 95] similar
prospective-cohort, unadjusted, lower quality analyses.
Baseline BML size in the lateral but not the medial tibiofe-
moral joint was associated with incident frequent knee
pain in a prospective-cohort, well-adjusted, high quality
analysis [125]. Longitudinally increasing BML size was as-
sociated with incident frequent knee pain in a similar but
inadequately adjusted analysis of below average quality
[126]. In cross-sectional studies the size or presence of
BMLs was inconsistently associated with the presence of aheterogenous range of pain measures, irrespective of
adequate covariate adjustment [22, 29, 48, 96, 97, 99,
101, 103, 125, 127–135]. In summary, BMLs are independ-
ently associated with longitudinally increasing pain severity
and are associated with incident frequent knee pain.Osteophytes
MRI (one cohort, eight cross-sectional, one case–control
study): one prospective cohort, unadjusted, below-average-
quality analysis reported increasing baseline osteophyte
size was associated with increasing WOMAC pain severity
score [28]. In well-adjusted cross-sectional analyses, osteo-
phyte size was associated with the presence [130] but
not severity of pain [136]. In unadjusted cross-sectional
analyses osteophytes were inconsistently associated with a
heterogenous range of pain measures [22, 97, 101, 103,
127, 137]. In summary, osteophytes are associated with
longitudinally increasing pain severity and the cross-
sectional presence of pain.Bone attrition
MRI (no cohort, two cross-sectional, one case–control
study); cross-sectional analyses found greater attrition
was associated with greater pain severity, without covari-
ate adjustment [103, 138], but not after adequate covariate
adjustment [138]. An unadjusted case–control analysis
found an association between attrition and prevalent pain
[139]. In summary, bone attrition is associated, but not in-
dependently so, with severity of pain.Bone shape/dimension
MRI (one cohort, one cross-sectional study): one prospect-
ive, well-adjusted, high quality analysis found the femoro-
tibial articulating surface mismatch was associated with
incident frequent knee pain [114]. One unadjusted cross-
sectional analysis found the irregularity of the femoral
condyle surface was associated with severity of knee pain
[47]. In summary, specific features of bone shape are inde-
pendently associated with incident frequent knee pain and
severity of pain.Bone cyst
MRI (one cohort, five cross-sectional, two case–control
studies): one prospective cohort, unadjusted, low quality
analysis found no association between bone cyst size and
increasing WOMAC pain score [28]. In mostly unadjusted
cross-sectional [22, 101, 103, 130, 137] and case control
analyses [139, 140] of heterogenous cyst measures and
pain measures, an association between cysts and pain was
inconsistently found. In summary, bone cysts may not be
associated with longitudinal severity of pain and cross-
sectional association with pain is uncertain.
Table 2 Knee pain associations by feature and quality score
Author Feature (method) Knee pain outcome Adjustment for confounders Association (magnitude)
crude
Association (magnitude)
adjusted
Association Quality score
(%)
MRI bone marrow lesion - cohort studies
Foong 2014 [21] Change in BML size (L)
and incident BMLs (L)
in all three knee
compartments
WOMAC Knee pain
severity at 2-year
and 10-year visits (L)
Age, sex, BMI, leg strength,
and the presence of ROA
NR Incident or change in total
BML size β = 1.53 (95 % CI
0.37 to 2.70.
+ High (67)
Medial tibial change in
BML size β = 2.96 (95 % CI
0.59-5.34
Incidence of BML or
increase in size
associated with increase
in pain in the medial tibia
Driban 2013 [72] Knee baseline BML
volume (C), BML
volume change
(L) (TFJ)
48-month change
in WOMAC pain (L)
Age, sex, BMI NR β = 0.21 + High (61)
(standard error 0.07) Longitudinal (L) changes
in BML correlated with
(L) changes in pain severityp = 0.004
Dore 2010 [124] MRI BML size (L)
regional or whole
TFJ over 2.7 years
Change in WOMAC
pain (L) over
2.7 years
Age, sex, BMI, leg strength,
quality of life, and baseline
pain, function
β (95 % CI) Total
BML size change =
1.06 (0.10 to 2.03)
β (95 % CI) total BML
size change = 1.13 (0.28
to 1.98)
+ High (56)
Kornaat 2007
[173]
Semi-quantitative
MRI BML change
over 2 years (L) TFJ
Mean WOMAC pain
over 2 years
Age, sex and BMI NR β (95 % CI) = 2 (−8 to 11) NA High (56)
Moisio
2009 [125]
Baseline MRI semi-
quantitative BML
score (C) TFJ and PFJ
Incident frequent
knee pain 2 years
after baseline (L)
Age, sex, BMI, BML score,
% denuded bone
NR OR (95 % CI) medial tibia
and femur 1.41 (0.86 to
2.33), lateral tibia and
femur 1.70 (1.07 to 2.69)
+ Lateral TFJ BML score
associated with incident
frequent knee pain
High (56)
Sowers 2011
[28]
Semi-quantitative MRI
BML, size in TFJ (C)
Increasing WOMAC
pain (L)
Nil Medial and lateral
TFJ BMLs both
p <0.005
NR + Low (53)
Zhang 2011
[126]
Semi-quantitative
change in MRI BML
size (L) TFJ over
30 months
Incidence of
frequent knee
pain, and categorical
severity (L) over
30 months
Synovitis and effusions OR (95 % CI) Severity
of frequent knee pain
OR 3.0 (1.5 to 6.0)
OR (95 % CI) Incident
frequent knee pain p for
trend = 0.006. Severity of
frequent knee pain OR
2.2 (1.0 to 4.7) p = 0.047
+ Ipsilateral association Low (50)
Wildi 2010 [95] 24-month change in
regional TFJ BML
score WORMS (L)
24-month change
in WOMAC pain (L)
Nil R <0.15, p >0.067 for
all compartments
NR NA, all compartments
had no correlation
Low (50)
Tanamas 2010
[89]
Baseline semi-
quantitative MRI BML
size (C)
Annual change in
WOMAC pain (L)
Nil NR NR NA Low (50)
MRI bone marrow lesion - cross-sectional studies
Zhai 2006 [135] Semi-quantitative MRI
BML (C)
WOMAC pain >1 (C) Age, BMI, sex, knee strength,
chondral defects
NR OR 1.44, 95 % CI 1.04, 2.00 + High (79)
Sharma 2014
[133]
Semi-quantitative BML
score WORMS TFJ or
PFJ (C)
Prevalent frequent
knee symptoms (C)
Age, sex, body mass index
(BMI), previous knee injury,
and previous knee surgery
NR BMLs in any compartment
OR 1.96, 95 % CI 1.38 to 2.77
+ BML association with
prevalent knee symptoms
High (71)
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Table 2 Knee pain associations by feature and quality score (Continued)
Kornaat 2006
[130]
Semi-quantitative MRI
BML (C)
Chronic pain
presence (C)
Age, sex, and BMI NR OR 1.13, 95 % 0.41, 3.11,
p = 0.76
NA High (71)
Lo 2009 [131] Semi-quantitative MRI
BML (BLOKS) (C)
WOMAC pain (C) Synovitis, effusion scores p for trend = 0.0009 p for trend = 0.006 + High (71)
Stefanik 2014
abstract [134]
BML (WORMS) (C)
(patellofemoral joint)
Prevalent knee pain
(any pain in last 30
days) and pain VAS (C)
Adjusted for age, sex, BMI,
depressive symptoms and
TFJ BMLs
NR Isolated BML of the lateral
PFJ, OR (95 % CI) 1.4 (0.9 to
2.0); medial PFJ, OR (95 % CI)
1.1 (0.8 to 1.5). Isolated
lateral PFJ BMLs OR 6.6 (1.7
to 11.5)
NC High (71)
Ratzlaff 2013
[132]
Total BML volume in
the femur or tibia (C)
Weight-bearing
knee pain WOMAC
subscale (C)
Age, sex, BMI, race, and
medial minimum joint
space width
NR Total BML volume femur
p = 0.003, tibia p = 0.101
+ Femoral NA Tibial High (71)
Ip 2011 [99] Semi-quantitative MRI
BML (C)
WOMAC pain (C) Age, sex, BMI, OA stage,
joint effusion, and meniscal
damage
NR Total WOMAC pain NC High (68)
R = 0.05, 95 % CI −0.04 to
0.14. Stair climbing pain
R = 0.09 (0.00 to 0.18)
Torres 2006
[103]
MRI BML (WORMS)
TFJ and PFJ (C)
Pain VAS (C) Age, BMI Coefficient 5.00,
95 % CI 3.00 to 7.00
Coefficient 3.72, 95 % CI
1.76 to 5.68
+ High (68)
Kim 2013 [129] Summary score and
severity of MRI BML
(WORMS) (C)
WOMAC pain
severity or presence
of knee pain (C)
Age, sex, BMI, radiographic
OA
NR BML summary score medial
TFJ OR 2.33, 95 % CI 1.02 to
5.33, p <0.001
+ Severity of BML is
proportional to WOMAC
in medial compartment
after adjustment
High (64)
Moisio 2009
[125]
Baseline MRI semi-
quantitative BML
score (C) TFJ and PFJ
Presence of baseline
moderate to severe
knee pain (C)
Percent denuded bone,
age, sex, BMI
NR Bone marrow lesion score,
OR 0.95, 95 % CI 0.63 to
1.44. Not significant in all
compartments
NA found on cross-sectional
analysis
High (64)
Ratzlaff 2014
[48] Abstract
Median BML volume
(PFJ, TFJ) (C)
Stair-climbing knee
pain WOMAC (C)
Nil TFJ p = 0.01,
patellofemoral p = 0.01,
femur p = 0.02, tibia
p = 0.03
NR + High (64)
Hayes 2005 [22] Semi-quantitative MRI
BML (C)
Chronic pain
presence (C)
Nil p = 0.001 NR + High (61)
Ai 2010 [127] Semi-quantitative MRI
BML (C)
Pain verbal rating
scale (Likert) (C)
Nil p = 0.33 NR NA Low (57)
Bilgici 2010
[128]
MRI BML (WORMS) (C) WOMAC pain, pain
VAS (C)
Nil WOMAC r = 0.508,
p <0.01 Pain VAS
r = 0.488, p <0.01
NR + Low (57)
Sowers 2003
[29]
Semi-quantitative MRI
BML (C)
Chronic pain
presence (C)
Nil OR 5.0, 95 % CI 2.4
to 10.5
NR + Low (54)
Link 2003 [101] Semi-quantitative MRI
BML (C)
WOMAC pain (C) Nil p >0.05 NR NA Low (54)
Felson 2001 [96] p <0.001 OR 3.31, 95 % CI 1.54 to 7.41 + Low (54)
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Table 2 Knee pain associations by feature and quality score (Continued)
Semi-quantitative MRI
BMLs (C)
Chronic knee pain
presence (C)
Radiographic severity, age,
sex, and effusion score
Fernandez-
Madrid
1994 [97]
Crude presence of MRI
BMLs (C)
Crude pain
presence (C)
Nil NR NR NA Low (46)
MRI bone marrow lesion - case−control studies
Javaid 2010
[140]
Baseline semi-
quantitative MRI BML
size (WORMS) (C) TFJ
and PFJ
Incident frequent
knee pain after
15 months (L)
Age, sex, race, BMI NR Whole knee OR 2.8, 95 % CI
1.2 to 6.5
+ High (76)
Felson 2007
[181]
Semi-quantitative MRI
BML size increase
(WORMS) (L) TFJ
and PFJ
Incident frequent
pain at 15 months
(L)
Age, sex, race, BMI,
quadriceps strength, KL
score, malalignment,
baseline BML score
OR 4.1, 95 % CI 2.1
to 8.1
OR 3.2, 95 % CI 1.5 to 6.8 + High (71)
Javaid 2012
[139]
Baseline Semi-
quantitative MRI BML,
(WORMS) (C) TFJ
and PFJ
Presence of
frequent knee
pain (C) after
2 years
Nil OR 1.70, 95 % CI
1.08 to
NR + Low (59)
Zhao 2010 [105] Baseline crude
presence of MRI BMLs
at (C) TFJ
Change in WOMAC
Pain (L)
Nil p = 0.60 NR NA Low (56)
Stahl 2011 [41] Semi-quantitative MRI
BML size (WORMS)
(L) TFJ
Changes in WOMAC
score (L)
Nil NR Data not shown NA Low (47)
MRI osteophyte – cohort studies
Sowers 2011
[28]
Semi-quantitative MRI
osteophyte, size in
TFJ (C)
Increasing WOMAC
pain (L)
Nil Medial and lateral
TFJ BMLs both
p <0.001
NR + Low (53)
MRI osteophyte - cross-sectional studies
Kornaat 2006
[130]
Semi-quantitative MRI
osteophyte (C)
Chronic pain
presence (C)
Age, sex, BMI NR Patellofemoral OR 2.25,
95 % CI 1.06 to 4.77
+ High (71)
Sengupta
2006 [136]
Semi-quantitative MRI
osteophyte (WORMS)
(C)
Pain severity
WOMAC, chronic
pain (C)
Age, sex, BMI NR OR 0.97, 95 % CI 0.86 to 1.10 NA High (71)
Torres 2006
[103]
MRI osteophyte,
(WORMS) TFJ and
PFJ (C)
Pain VAS (C) Nil Coefficient 1.18,
95 % CI 0.63 to 1.72
Coefficient 0.50, 95 % CI
0.07 to 0.94
NC High (68)
Hayes 2005 [22] Semi-quantitative MRI
osteophyte (C)
Chronic pain
presence (C)
Nil p <0.001 NR + High (61)
Ai 2010 [127] Semi-quantitative MRI
osteophytes (C)
Pain verbal rating
scale (Likert) (C)
Nil p = 0.166 NR NA Low (57)
Hayashi 2012
[137]
Crude presence of
MRI osteophytes (C)
Nil OR 4.2 to 6.4, p =
0.001-0.011
NR + Low (57)
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Table 2 Knee pain associations by feature and quality score (Continued)
Presence of pain
on WOMAC pain
subscale (C)
Link 2003 [101] Semi-quantitative MRI
osteophytes (C)
WOMAC pain (C) Nil p >0.05 NR NA Low (54)
Fernandez-
Madrid 1994
[97]
Crude presence of MRI
osteophytes (C)
Crude pain
presence (C)
Nil NR NR NA Low (46)
MRI osteophyte - case–control studies
Javaid 2010
[140]
Baseline semi-
quantitative MRI
osteophyte, size
(WORMS) (C) TFJ
and PFJ
Incident frequent
knee pain after
15 months (L)
Age, sex, race, BMI NR Whole knee severe osteophyte
OR 4.7, 95 % CI 1.3 to 18
+ High (76)
MRI bone attrition - cross-sectional studies
Hernandez-
Molina 2008
[138]
Semi-quantitative MRI
bone attrition
(WORMS) (C)
Pain severity and
nocturnal pain
(WOMAC) (C)
Age, sex, BMI, BMLs,
effusions and KL grade
OR (95 % CI) pain
severity OR 1.6 (1.1
to 2.3), nocturnal
pain OR 1.1 (0.5
to 2.1)
OR (95 % CI) pain severity
OR 0.9 (0.6 to 1.4), nocturnal
pain OR 1.0 (0.5 to 2.1).
NA High (71)
Torres 2006
[103]
MRI attrition, (WORMS)
TFJ and PFJ (C)
Pain VAS (C) Nil Coefficient 3.33,
95 % CI 1.79 to 4.87
Coefficient 1.91, 95 % CI 0.68
to 3.13
+ High (68)
MRI bone attrition - case−control studies
Javaid 2012
[139]
Baseline semi-
quantitative MRI
attrition size (WORMS)
(C) TFJ and PFJ
Presence of
frequent knee
pain (C) after
2 years
Nil OR 2.40, 95 % CI
1.51 to 3.83
NR + Low (59)
MRI bone shape/dimension - cohort studies
Everhart 2014
[114]
Baseline TFJ
subchondral surface
ratio of medial and
lateral TFJ
compartments (C)
Incident frequent
knee pain at
48 months, (L)
Sex, race, age, BMI, tobacco
use, activity level, knee
coronal alignment, baseline
symptoms, injury history,
surgery history, KL grade,
and JSW
NR Medial SSR OR 0.48, 95 % CI
0.30 to 0.75, p = 0.0009.
Lateral SSR OR 1.27, 95 % CI
0.86 to 1.88, p = 0.19
- larger MSSR gets less
incident frequent knee pain
High (61)
MRI bone shape/dimension - cross-sectional studies
Ochiai 2010 [47] MRI irregularity of
femoral condyle
contour (C)
Knee pain VAS (C) Nil Irregularity of femoral
condyle contour
r = 0.472, p = 0.0021
NR + Low (50)
MRI bone cyst - cohort studies
Sowers 2011
[28]
Semi-quantitative MRI
bone cyst size in
TFJ (C)
Increasing WOMAC
pain (L)
Nil NR NR analysis described as not
significant but data not shown
NA Low (53)
MRI bone cyst - cross-sectional studies
Barr
et
al.A
rthritis
Research
&
Therapy
 (2015) 17:228 
Page
22
of
36
Table 2 Knee pain associations by feature and quality score (Continued)
Kornaat 2006
[130]
Semi-quantitative MRI
bone cyst(C)
Chronic pain
presence (C)
Nil NR Patellofemoral OR 1.83,
95 % CI (0.80 to 4.16)
NA High (71)
Torres 2006
[103]
MRI bone cyst
(WORMS) TFJ and
PFJ (C)
Pain VAS (C) Age, BMI Coefficient 2.50,
95 % CI −0.38 to 5.38
Coefficient 0.82, 95 % CI
−0.50 to 2.14
NA High (68)
Hayes 2005 [22] Semi-quantitative MRI
bone cyst (C)
Chronic pain
presence (C)
Age, sex, and BMI p <0.001 NR + High (61)
Hayashi 2012
[137]
Crude presence of MRI
bone cysts (C)
Presence of pain
on WOMAC pain
subscale (C)
Nil OR 6.7 to 17.8, p =
0.004 to 0.03
NR + Low (57)
Link 2003 [101] Crude presence of MRI
bone cyst (C)
WOMAC pain (C) Nil p >0.05 NR NA Low (54)
MRI bone cyst - case control studies
Javaid 2010
[140]
Baseline semi-
quantitative MRI bone
cyst size (WORMS) (C)
TFJ and PFJ
Incident frequent
knee pain after
15 months (L)
Nil NR NR p >0.1 NA High (76)
Javaid 2012
[139]
Baseline semi-
quantitative MRI bone
cyst size (WORMS) (C)
TFJ and PFJ
Presence of
frequent knee
pain (C) after
2 years
Nil OR 1.61, 95 % CI
1.03 to 2.52
NR + Low (59)
qCT bone mineral density - cross-sectional studies
Burnett 2012
[57]
BMD of patellar lateral
facet (qCT) (C)
WOMAC – knee
pain at rest (C)
Nil Total lateral patella
facet p = 0.04, inferior
lateral facet p = 0.005
NR Low (57)
2D Knee bone shape - cross-sectional studies
Haverkamp 2011
[36]
2D Bone shape knee,
1. femur and tibial
width, 2. elevation of
lateral tibial plateau (C)
Pain severity VAS (C) Models adjusted for Age,
BMI
NR Bone width p = 0.167,
lateral tibia plateau elevation
p = 0.002
+ Lateral tibial plateau
associated with pain
severity, NA bone width
with pain severity
Low (46)
Positive correlation reported between bone feature and outcome measure (+); negative correlation reported between bone feature and outcome measure (−). BMI body mass index, BML bone marrow lesion, C a feature or
outcome described in cross-section, knee pain on most days for at least the last month (chronic pain) confidence interval (CI), KL Kellgren-Lawrence, L a feature or outcome described longitudinally, NA no association, NC no
conclusion could be found for an association between bone feature and outcome measure, NR not reported, OA osteoarthritis, OAI Osteoarthritis Initiative, OR odds ratio, PFJ patellofemoral joint, ROA radiographic
osteoarthritis, SSR subchondral surface ratio VAS visual analogue scale, WOMAC Western Ontario and McMaster Universities arthritis index, qCT quantitative computed tomography
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One inadequately adjusted cross-sectional analysis found
an association between the elevation of the lateral tibial
plateau and severity of pain [36]. In summary, 2D lateral
tibial bone shape is associated with cross-sectional sever-
ity of pain.
Relationship between hand bone feature and structural
progression
The association between bone features and structural
progression is described in Tables 3 and 5.
Bone marrow lesions
MRI (one case series, two cross-sectional studies): one
well-adjusted, high quality analysis of a prospective OA
case series, found that increasing BML number and size
in the interphalangeal joints at baseline conferred greater
odds of structural progression of OA [141]. Two adjusted
cross-sectional analyses found increasing BML number
and size scores were associated with increasing severity of
structural progression [142, 143]. In summary, BMLs are
independently associated with structural progression of
hand OA.
Osteophyte attrition and cysts
One cross-sectional, adjusted analysis found greater MRI
attrition or MRI osteophyte number and size was associ-
ated with greater structural severity [142]. However, greater
presence of cysts observed on MRI was not associated
with greater structural severity of OA [142]. In summary,
osteophytes and attrition, but not cysts, are associated
with structural severity of hand OA.
Relationship between hand bone feature and pain
The association between bone features and pain is described
in Tables 4 and 5.
Bone marrow lesions
MRI (one case series, one cross-sectional study): one well-
adjusted, high quality analysis of a prospective OA case
series, found that BML number and size at baseline was
not associated with longitudinal change in hand pain
[144]. One adjusted cross-sectional analysis found no as-
sociation of BMLs with severity of pain [145]. In summary,
BMLs are not independently associated with longitudinal
or cross-sectional severity of pain.
Osteophyte attrition and cysts
One cross-sectional, adjusted analysis found no association
between bone features, osteophytes, attrition or cysts
observed on MRI, and pain severity [145]. In summary,
osteophytes, attrition and cysts are not associated with
severity of hand pain.Scintigraphy
Scintigraphy (one cross-sectional study): one cross-sectional
unadjusted analysis found no significant association between
bone signal in the hands and severity of pain. In summary,
bone scintigraphy signal is not associated with severity
of pain in hand OA.
Relationship between hip bone feature and structural
progression
The association between bone features, and structural
progression and joint replacement is described in Tables 3
and 5.
Bone marrow lesions
MRI (two cross-sectional studies): one well-adjusted [69]
and one unadjusted [46] cross-sectional analysis both
found that BMLs were associated with greater structural
severity. In summary, BMLs are associated with structural
severity of hip OA.
Trabecular bone morphometry
One unadjusted cross-sectional analysis found greater MRI
bone volume fraction, trabecular thickening, trabecular
number and lower trabecular spacing were associated with
greater structural severity of OA [33]. In summary, bone
volume fraction, trabecular thickening, number and spa-
cing are associated with structural severity in hip OA.
Peri-articular bone mineral density
DXA (two cross-sectional studies): one well-adjusted [30]
and one adjusted [32] cross-sectional analysis found greater
BMD was associated with greater structural severity. In
summary, BMD is associated with structural severity of
hip OA.
2D and 3D hip bone shape
Hip bone shape (three cohort, two cross-sectional, three
case–control studies): in two prospective cohort, well-
adjusted, high quality analyses increasing asphericity of
the femoral head (measured as an elevated alpha angle,
or in shape modes 11 and 15) was associated with total
hip replacement (THR) [146] or with structural progression
and THR [147] respectively. In one prospective cohort,
well-adjusted, high quality analysis, acetabular undercover-
age of the femoral head (a low centre-edge angle) was asso-
ciated with structural progression or THR [148]. In one
well-adjusted cross-sectional analysis, 2D asphericity de-
formity of the femoral head (cam-type deformity) was asso-
ciated with structural severity [149]. In one well-adjusted
cross-sectional analysis of MRI-determined femoral head
asphericity in asymptomatic young men, there was a signifi-
cantly lower cartilage thickness in those with than those
without any detectable asphericity. This became insignifi-
cant after covariate adjustment [27]. Case–control analyses
Table 3 Hand, hip and ankle structural associations by feature and quality grade
Author Feature (method) Structural severity or
progression outcome
Adjustment for confounders Association (magnitude)
crude
Association (magnitude)
adjusted
Association Quality
(score %)
Hand MRI bone marrow lesion case series
Haugen 2014
[141]
BMLs - semi-quantitative
at 2nd to 5th IPJs (C)
Progression of hand
ROA (JSN, KL grade
or new erosion) (L)
Age, sex, BMI, OR 2.73, 95 % CI 1.29
to 5.78
NR + High (61)
Bigger the BML, the
more the JSN
Hand MRI bone marrow lesion cross-sectional studies
Haugen 2012
Abstract [143] 299
BML (Oslo MRI hand
score) (C) IPJs
Radiographic JSN
grade IPJ (OARSI
atlas) (C)
Age, sex, OR 10.0, 95 % CI 4.2
to 23
OR 4.4, 95 % CI 2.2 to 9.0 + Low (43)
BML score association
with more JSN
Haugen 2012
[142]
BML (Oslo MRI hand score)
(C) IPJs
Hand KL grade of
IPJs (C)
Age, sex NR OR (95 % CI) + High (64)
BMLs 11 (5.5 to 21)
p <0.001
Hand MRI osteophyte cross-sectional studies
Haugen 2012
[142]
Osteophyte (Oslo MRI hand
score) (C) IPJs
Hand KL grade of
IPJs (C)
Age, sex NR OR (95 % CI) + High (64)
osteophytes
415 (189 to 908)
p <0.001
Hand MRI attrition cross-sectional studies
Haugen 2012
[142]
Attrition (Oslo MRI hand
score) (C) IPJs
Hand KL grade of
IPJs (C)
Age, sex NR OR (95 % CI) attrition 87
(37 to 204)
+ High (64)
p <0.001
Hand MRI bone cyst cross-sectional studies
Haugen 2012
[142]
Cyst (Oslo MRI hand score)
(C) IPJs
Hand KL grade of
IPJs (C)
Age, sex NR OR (95 % CI) Nil High (64)
cysts 2.0 (0.6 to 6.3)
p = 0.26
Hip MRI BML cross-sectional studies
Neumann 2007
[46]
Semi-quantitative BMLs (C) Semi-quantitative
cartilage lesions (C)
Nil R = 0.44, p ≤0.001 NR + Correlation between
BML and cartilage lesions
Low (43)
Dawson 2013
Abstract [69]
Femoral head BMLs (MRI) (C) 1. Presence of hip
OA. 2. Femoral
head cartilage
volume (MRI) (C)
Age, sex, BMI NA OA hip presence + Low (14)
BMLs associated with
diagnosis of hip OA
OR (95 % CI)
5.32 (1.78 to 15.9)
p = 0.003 BMLs inversely associated
with cartilage volume
cartilage volume
regression coefficient
(95 % CI)
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Table 3 Hand, hip and ankle structural associations by feature and quality grade (Continued)
−245.7 mm3
(−456 to −36) p = 0.02
Hip CT bone morphometry cross-sectional studies
Chiba 2011 [33] Acetabular and femoral
head subchondral trabecular
morphometry: bone volume
fraction, trabecular thickness,
number, separation (CT) (C)
Hip joint space
volume (CT) (C)
Nil Femoral head Bone
volume fraction
r = −0.691, p <0.001
NR Joint space narrowing
is associated with
increased bone volume
fraction, trabecular
thickening. trabecular
number and spacing
decrease
Low (57)
Hip DXA BMD cross-sectional studies
Chaganti 2010
[30]
Femoral neck BMD (C) DXA Hip ROA Modified
Croft score
(categorical 0–4) (C)
Age, BMI, height, activity
level, race, 6-m walk pace,
Nottingham muscle
strength, inability to do
chair stands, and clinic site,
NR p <0.0001 + High (64)
Higher BMD for higher
grade of OA of hip
Antoniades 2000
[32]
DXA BMD of the femoral
neck of left (nondominant)
hip with ROA (C)
Radiographic OA
(Croft score) (C)
BMI, lifetime physical activity,
menopausal status, use of
oestrogen, and smoking
OR 1.63, 95 % CI 1.06
to 2.50)
OR 1.80, 95 % CI 1.05
to 3.12
+ Association between
BMD and hip ROA
grade in the index hip
High (64)
Higher OA grade means
higher BMD
2D Hip bone shape longitudinal studies
Agricola 2013
[146]
Baseline 2D femoral and
acetabular shape modes
(segmented by statistical
shape modelling) (C)
THR at or within
5 years (L)
Age, sex, BMI, shape modes 5 modes were
associated with THR
OR 1.71 to 2.01,
p ≤0.001
3 modes were associated
with THR OR 1.78 to 2.10,
p ≤0.001
+ Increasing femoral
head asphericity is
associated with THR
High (72)
Agricola 2013
[147]
Baseline alpha angle (2D
femur shape) dichotomous
abnormal >60 °, normal
≤60 ° (C)
Incident ROA hip
(KL >1), incident
end-stage ROA
hip (KL >2 or THR)
at or within 5 years
(L)
Age, sex, BMI, KL grade OR (95 % CI) Incident
ROA hip 6.82 (3.55
to 13.10) p <0.0001
OR (95 % CI) incident
ROA hip 2.42 (1.15 to
5.06) p = 0.02, incident
severe ROA or THR 3.67
(1.68 to 8.01) p <0.0001
+ Elevated alpha
angle is associated
with incident end-
stage OA hip
High (67)
Agricola 2013
[148]
Baseline 2D centre edge
angle (acetabular shape):
25 ° <normal <40 °,
undercoverage <25 °,
overcoverage >40 ° (C)
Incidence within
5 years of: 1. ROA
hip (KL >1), 2. end-
stage OA (KL >2
or THR)
Age, sex, BMI, KL grade OR (95 % CI)
overcoverage 0.52
(0.19 to 1.43) p = 0.21,
undercoverage 3.64
(1.91 to 6.99) p = 0.00
OR (95 % CI) overcoverage
0.34 (0.13 to 0.87) p =
0.025, undercoverage
5.45 (2.40 to 12.34)
p = 0.00
Overcoverage is
protective against
OA incidence (−).
Undercoverage is
associated with
greater odds of OA
incidence and end-
stage OA (+)
High (67)
2D and 3D hip bone shape cross-sectional studies
Gosvig 2010 [149] Categorical hip 2D deformity:
1. normal, 2.‘pistol grip’,
3) deep acetabular socket (C)
Presence of
radiographic hip OA
(JSW ≤2 mm) (C)
Age, sex, BMI, other hip
deformities
NR RR (95 % CI) pistol grip
2.2 (1.7 to 2.8) p <0.001,
deep acetabular socket
+ Low (50)
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Table 3 Hand, hip and ankle structural associations by feature and quality grade (Continued)
2.4 (2.0 to 2.9) p <0.001,
normal (p >0.05)
Reichenbach
2011 [27]
The presence or absence of
any 3D semi-quantitative
MRI-defined cam-deformity
(C)
Combined femoral
and acetabular
cartilage thickness
(C)
Age, BMI (NB all participants
were young men)
Unadjusted mean
cartilage thickness
difference with CAM
deformity −0.24 mm
(95 % CI −0.46 to −0.03)
Adjusted mean cartilage
thickness difference with
CAM deformity −0.19 mm
(95 % CI −0.41 to 0.02)
NC High (64)
2D hip bone shape case control studies
Doherty 2008 [43] Non-spherical femoral head
2D shape assessment:
1. appearance of ‘pistol grip
deformity’ (C), 2. maximum
femoral head diameter ratio
to minimum parallel femoral
neck diameter (C)
Presence of
radiographic hip
OA (JSW ≤2.5
mm) (C)
Age, sex, BMI, BMD, physical
activity, history of hip injury,
type 3 hand (index finger
shorter than ring finger),
hand nodes, and center-
edge angle
OR (95 % CI) pistol grip
deformity 5.75 (4.00 to
8.27). Femoral head-to-
neck ratio 10.45 (7.16
to 15.24)
OR (95 % CI) pistol grip
deformity 6.95 (4.64 to
10.41). Femoral head-to-
neck ratio 12.08 (8.05
to 18.15)
+ Low (53)
Barr 2012 [150] 2D Shape measures of
centre-edge angle (acetabular
shape) (C)
THR vs no
radiographic
progression over
5 years (L)
Age, gender, BMI KL grade,
use of walking stick, WOMAC
function, duration of pain
OR (95 % CI) mode 2
0.74 (0.50 to 1.10)
p >0.05
OR (95 % CI) Mode 2
0.17 (0.04 to 0.71)
p <0.05
NB, this model
association is inverse
and correlates with
acetabular shape
High (76)
Nicholls 2011 [39] CAM deformity; mean
modified triangular index
height, alpha angle. 2D
acetabular dysplasia; mean
lateral center edge angle, (C)
Total hip
replacement (L)
BMI, age OR (p value) triangular
index 1.131 (0.021).
Alpha angle 1.056
(<0.0005). Centre edge
angle 0.906 (0.004)
OR (p value) Triangular
index 1.291 (0.011).
Alpha angle 1.057
(<0.0005). Centre- edge
angle 0.887 (0.002)
+ Association of hip
replacement with
CAM impingement
and acetabular
dysplasia indicated
by these results
High (71)
Ankle scintigraphic subchondral bone cross-sectional studies
Kraus 2013 [60] Ipsilateral late phase bone
scintigraphy, retention
presence in tibiotalar
joint (C)
Tibiotalar ROA KL
grade and JSN (C)
Age, gender, BMI NR KL grade r = 0.49,
p <0.0001. JSN r =
0.35, p <0.0001
+ High (71)
Knupp 2009 [24] Late phase bone scintigraphy,
semi-quantitative retention
scoring of tibiotalar joint (C)
Tibiotalar ankle joint
JSN. (modified
Takakura score) (C)
Nil 0.62 to 0.75 (p <0.01) NR + Low (57)
Positive correlation was reported between bone feature and outcome measure (+); negative correlation reported between bone feature and outcome measure (−).BMD bone mineral density, BML bone marrow lesion,
C a feature or outcome described in cross-section, CT computed tomography, DXA dual-energy x-ray absorptiometry, HOAMS Hip osteoarthritis MRI scoring system, IPJ interphalangeal joint, JSN joint space narrowing,
JSW joint space width, KL Kellgren-Lawrence, L a feature or outcome described longitudinally, NA no association, NC no conclusion could be found for an association between bone feature and outcome measure, MRI magnetic
resonance imaging, PFJ patellofemoral joint, ROA radiographic osteoarthritis, OA osteoarthritis, OARSI Osteoarthritis Research Society International, OR odds ratio, RR relative risk, TFJ tibiofemoral joint, THR total hip re-
placement, TKR total knee replacement, VAS visual analogue scale, WOMAC Western Ontario and McMaster Universities arthritis index, WORMS whole-organ magnetic resonance imaging score
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Table 4 Hand and hip pain associations by feature and quality score
Author Feature (method) Pain outcome Adjustment for
confounders
Association (magnitude)
crude
Association (magnitude)
adjusted
Association Quality score (%)
Hand MRI bone marrow lesion case series
Haugen 2014 Abstract
[144]
Sum scores (0–48) for BMLs
(Oslo hand OA MRI score) (C)
AUSCAN pain scale (L) Age, sex, BMI,
follow-up time
NR β = −0.26, 95 % CI
−0.55 to 0.03
NA High (61)
Hand MRI bone marrow lesion cross-sectional studies
Haugen 2012 [145] BML (Oslo MRI hand score)
(C) IPJs sum scores
AUSCAN pain scale (C) Age, sex NR OR (95 % CI) 0.96
(0.82 to 1.12)
NA High (64)
Hand MRI osteophyte cross-sectional studies
Haugen 2012 [145] Osteophyte (Oslo MRI hand
score) (C) IPJs sum scores
AUSCAN pain scale (C) Age, sex NR OR (95 % CI) 1.04
(0.98 to 1.10)
NA High (64)
Hand MRI attrition cross-sectional studies
Haugen 2012 [145] Attrition (Oslo MRI hand
score) (C) IPJs sum scores
AUSCAN pain scale (C) Age, sex NR OR (95 % CI) 1.15
(0.98 to 1.34)
NA High (64)
Hand MRI subchondral cyst cross-sectional studies
Haugen 2012 [145] Cyst (Oslo MRI hand score)
(C) IPJs sum scores
AUSCAN pain scale (C) Age, sex NR OR (95 % CI) 0.93
(0.56 to 1.55)
NA High (64)
Hand scintigraphy subchondral bone cross-sectional studies
Macfarlane 1993 [61] Late phase isotope bone scan
small joints of the hand (C)
Hand pain VAS (C) Nil Correlation coefficient
0.06, p = 0.304
NR NA Low (57)
Hip MRI bone marrow lesion cross-sectional studies
Kumar 2013 [151] Total hip semi-quantitative
BML score (C)
Self-reported hip pain
HOOS score (C)
Nil NR p correlation −0.29
(p <0.01)
A higher BML score means
a lower or worse HOOS
pain score
High (71)
Maksymowych 2014
[152]
Semi-quantitative BML HIP
(HOAMS) (C)
Baseline WOMAC pain (C) Nil p <0.001 NR + High (64)
Hip MRI subchondral cyst cross-sectional studies
Kumar 2013 [151] Total hip semi-quantitative
subchondral cyst score (C)
Self-reported hip pain
HOOS score (C)
Nil NR p correlation −0.37
(p <0.001)
A higher cyst score means a
lower or worse HOOS pain
score
High (71)
Positive correlation reported between bone feature and outcome measure (+); negative correlation reported between bone feature and outcome measure (−). AUSCAN Australian/Canadian Osteoarthritis hand index,
BML bone marrow lesion, C a feature or outcome described in cross-section, chronic pain knee pain on most days for at least the last month, HOAMS Hip osteoarthritis MRI scoring system, HOOS Hip dysfunction and
osteoarthritis outcome score, IPJ interphalangeal joint, L a feature or outcome described longitudinally, NA no association, NR not recorded, OA osteoarthritis, OR odds ratio, VAS visual analogue scale
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Table 5 The summary subchondral bone associations with joint replacement, structural progression and pain in peripheral OA
Subchondral bone feature of
OA
Pain and structural associations
Knee structure Knee pain Hand structure Hand pain Hip structure Hip pain Ankle structure
MRI bone marrow lesions Progression (i) LPS (i) Progression (i) No LPS (w) Severity (w) Severity (n)
IFP (n) No severity (n)TKR (i)
MRI osteophytes Progression (i) LPS (n) Severity (n) No severity (n)
TKR (n)
MRI bone attrition No progression (0) No severity (0) Severity (n) No severity (n)
MRI bone shape or dimensions Progression (i) IFP (i) No severity (0)
Severity (n)TKR (i)
MRI bone cyst No progression No LPS (n) No severity (n) No severity (n) Severity (n)
?severity
MRI or CT trabecular
morphometry
Progression (n) Severity (n)
DXA or CT Peri-articular BMD Progression (n) Severity (w)
2D Bone shape Severity (w) Severity (n) Progression (i)
THR (i)
Scintigraphy No Progression (0) No severity (n) Severity (w)
CT computed tomography, dual-energy DXA x-ray absorptiometry, (i) independent association, IFP incident frequent pain, (n) association with no or inadequate
covariate adjustment, TKR total knee replacement, THR total hip replacement, LPS mean change in longitudinal pain severity, (w) well-adjusted association, (0)
association insignificant after covariate adjustment
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[39, 43, 150]. In summary, asphericity of the femoral head
and acetabular undercoverage of the femoral head are
independently associated with structural progression and
THR.
Relationship between hip bone feature and pain
The association between bone features and pain is described
in Tables 4 and 5.
Bone marrow lesions
MRI (two cross-sectional studies): two cross-sectional, un-
adjusted analyses found that increasing semi-quantitative
BML scores were associated with greater severity of pain
[151, 152]. In summary, BMLs are associated with severity
of pain in hip OA.
Bone cyst
One cross-sectional, unadjusted analysis found that in-
creasing semi-quantitative cyst scores on MRI were associ-
ated with greater severity of pain [151]. In summary: cysts
are associated with severity of pain in hip OA.
Relationship between ankle bone features and structural
progression
The association between bone features and structure is
described in Table 3 and 5.Scintigraphy
Scintigraphy (two cross-sectional studies): one well-adjusted
[59] and one unadjusted [62] cross-sectional analysis found
the presence or semi-quantitative scoring of late-phase bone
signal in the tibiotalar joint was associated with greater
structural severity. In summary, bone scintigraphy signal
is associated with ankle structural severity.
Discussion
This systematic review is the first to have incorporated
quality scoring alongside statistical adjustment in the
comprehensive examination of the relationship of sub-
chondral bone pathology with both structural progression
of OA and pain for all non-conventional types of radio-
graphic imaging of peripheral joints with OA. This sys-
tematic review has concluded that there are independent
associations between imaging-assessed bone pathology
and structural progression and pain in the knee, hand, and
hip.
Subchondral bone pathology may lead to cartilage de-
generation by altering the biomechanical force distribution
across joint cartilage, or disruption of the osteochondral
junction and release of soluble biomediators influencing
the cartilage [153, 154]. In OA the homeostatic process of
subchondral bone remodeling fails, leading to increased
bone turnover, volume and change in stiffness and shock-
absorbing capacity [155–157]. BMLs histologically repre-
sent increased bone turnover [158]. Cartilage overlying
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than healthy bone in knees from human cadavers [159].
That study, and an excluded study [160], concur with
the independent association between BMLs, and struc-
tural progression of OA in knees and hands and total
knee replacement, as concluded by this analysis. Although
randomised control trials were not excluded from this
review, several such trials were excluded on the basis of
failure to formally quantify any correlation between BMLs
and structural progression outcomes. These include the
strontium [161], intensive weight-loss therapy [162] and
glucosamine [163] trials, and some of these describe a con-
cordant reduction in BML size and cartilage volume loss.
Osteophytes represent subchondral bone hypertrophy
typical of OA. They represent endochondral and direct
bone formation and create a circumferential increase in
bone area around each knee cartilage plate, particularly
on the medial side in OA [118], which concurs with the
independent association between osteophytes demonstrated
on MRI and structural progression as observed in this
analysis.
In terms of bone morphology, knee OA is associated
with shallow trochlear patellar grooves in multiple epi-
physeal dysplasia [164]. These findings concur with the
findings of Stefanik and Kalichman, and colleagues in
studies of knee OA in this review [115, 116, 165]. Anterior-
cruciate ligament (ACL) rupture represents a risk factor
for developing knee OA. In cases of ACL tear in previously
normal knees of young healthy adults, the 3D shape of the
femur, tibia and patella expands more rapidly than in
controls without radiographic evidence of knee OA in
the subsequent 5 years [166]. The 3D shape of the same
knee bones has also been associated with the outcome
of joint replacement [167]. This highlights the import-
ance of bone shape and concurs with our conclusion
that 3D knee shape and 2D hip shape are independently
associated with structural progression of OA and total
joint replacement.
We found that bone attrition and cysts were associated
with structural progression or severity, but not after co-
variate adjustment, which included other OA subchon-
dral bone features. This suggests these bone features
are an epiphenomenon of the pathogenic process of
structural progression rather than a primary cause.
This hypothesis is supported by bone cysts and
attrition frequently occurring synchronously with BMLs
[88, 138] and incident bone attrition has been strongly
associated with the presence of BMLs within the same
compartment [168].
Increasing bone volume fraction, trabecular number
and thickness, but decreasing trabecular spacing on CT
and MRI studies were associated with structural progres-
sion. These specific associations concur with numerous
histological analyses of peripheral joint OA [169–171].Subchondral bone, particularly BMLs, have been found
to be associated with pain in knee, hip and hand OA.
However, some analyses, in which pain was measured
using heterogenous pain outcomes, report an absence of
longitudinal or cross-sectional association with BMLs
[101, 172, 173]. Furthermore, previous systematic reviews
have concluded moderate association at the most between
BMLs and knee pain [7, 14]. With the benefit of incorp-
orating more well-adjusted analyses in this systematic
review, we have highlighted that BMLs are independently
longitudinally associated with change in severity of pain,
but are only associated with incident frequent knee pain.
In analyses excluded from the current review, incident
knee BMLs predicted incident knee pain in healthy
community-based adults at risk of OA [174]. Concurrent
trends in reduction of pain and BML size were observed
in the zoledronic acid trial [175] and the intensive diet
and exercise for arthritis trial [176]. These were not in-
cluded because they did not make a formal comparison
of pain and BMLs. The mechanism by which BMLs may
cause pain is unknown but may include subchondral
microfractures, angina from a decreased blood supply caus-
ing ischaemia, and raised intraosseous pressure [177–179].
The independent association between a mismatch of
the femoral and tibial articulating surface areas and inci-
dent frequent knee symptoms indicates that bone shape
may predict not only the incidence of radiographic knee
OA [120], but also symptomatic OA.
In terms of limitations, stratifying observational studies
by quality may artificially create relatively high quality
studies from a collection of generally low quality stud-
ies. However the distribution and summary statistics of
quality scores indicate a suitably broad range of quality,
particularly in the influential cohort studies with a mean
of 54 % and range of 22−83 %. The decision to exclude
articles reporting analysis of association that included
fewer than 20 patients with OA may seem arbitrary. How-
ever, several papers report associations with the presence
or absence of pain or structural progression based upon
small numbers of patients. Our threshold decision reflects
the absence of specific guidelines on how to exclude such
papers, with inherent risk of imprecision, in the context
of heterogenous populations and statistical analyses. Had
these papers been included there would have been no
change in any of the conclusions in Table 5 (data not
shown). The use of joint replacement as an outcome
measure has a number of limitations including the ef-
fect of patient willingness, variation in orthopaedic opin-
ion, availability of health services and health insurance,
and therefore may be influenced depending upon the
country and context in which the study is performed.
Publication bias could not be assessed with a funnel
plot as there were insufficient results for odds and rela-
tive risk ratios. The heterogenous nature of the measures
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cluded a meta-analysis or calculation of an effect size. This
was because there were insufficient analyses describing
the same association between the same bone features and
outcome measure pair.
Conclusions
In conclusion subchondral bone plays an integral role in
the pathogenesis of OA. BMLs, osteophytes identified on
MRI and tibial bone area are independently associated
with structural progression of knee OA. BMLs and tibial
bone area are independently associated with TKR. BMLs
are independently associated with structural progression
of hand OA and 2D hip bone shape is associated with
progression of structural hip OA and THR. BMLs are
independently associated with longitudinal change in
severity of pain and femorotibial articulating area mis-
match is independently associated with incident frequent
knee pain. These bone features may be used in the future
for targeting treatment, stratifying patients into those
most in need of OA modification and measuring treat-
ment response.
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